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Sammendrag (norsk): 
Tilstandsundersøkelsene i Nordsjøen har det siste tiår vist gentoksiske effekter (DNA-addukter) i fisk samlet inn i 
områder med offshore olje- og gassvirksomhet. Kilden og identiteten til de gentoksiske forbindelsene har til nå ikke 
blitt identifisert. Målsetningen for prosjektet har vært å studere dannelsen av DNA-skade i hyse som utsettes for ulike 
petrogene eller pyrogene polyaromatiske hydrokarboner (PAH). Målet har vært å identifisere kildene til 
forurensningen som medfører DNA-addukter observert i hyse fanget rundt oljefeltene i Nordsjøen.  Dannelsen av 
DNA-skade over tid i hyse under kronisk eksponering for PAH og andre oljehydrokarboner fra følgende kilder er blitt 
studert: Ekstrakter av produsert vann (Statfjord A); destillasjonsfraksjoner av råolje fra Gullfaks (representere 
oljebasert borevæske); pyrogene PAH. Denne rapporten presenterer resultatene av studiene på DNA addukter i hyse 
og et utvalg av andre biologiske effektparametre.   
Summary (English): 
The Condition Monitoring in the North Sea the last ten years have documented genotoxic effects (DNA adduct) in 
fish collected in areas with extensive offshore oil and gas activity. However, the source and identity of genotoxic 
compound has not been identified. The objective of this project has been to study the formation of DNA damage in 
haddock exposed to petrogenic or pyrogenic polyaromatic hydrocarbons (PAHs) from different sources: Extracts of 
produced water (Statfjord A); distillation fractions of crude oil from Gullfaks (representing oil based drilling mud); 
pyrogenic PAH This report presents all the results from the study on DNA adducts and a selection of other biological 
effect parameters. 
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Abbreviations 
AhR   Aryl hydrogen receptor 
AHRR   Aryl hydrocarbon receptor repressor 
BAA    Benz(a)anthracene 
BAP   Benzo(a)pyrene 
BBF    Benzo(b)fluoranthene 
BEP   Benzo(e)pyrene 
BKF    Benzo(k)fluoranthene 
BP    Benzo(ghi)perylene 
BPDE-dG   benzo(a)pyrene (BP)-7,8-diol-9,10-epoxide-N(2)-deoxyguanosine 
C    Chrysene 
CYP1A   Cytochrome P4501A 
DBA    Dibenz(a,h)anthracene 
DE   Diol epoxide  
DMSO    Dimethyl sulfoxide 
dR   Deoxyribose  
ELISA   Enzyme-linked immunosorbent assay 
EROD    Ethoxyresorufin-O-deethylase 
FA    Fatty acid 
FF   Fixed wavelength fluorescence analysis 
FL    Fluoranthene 
GADD    DNA damage inducible proteins 
GC-MS   Gas chromatography mass spectrometry 
GC-MS/MS   Gas chromatography tandem mass spectrometry 
GST   Glutathione-S-transferase activity 
IND    Indeno(1,2,3-cd)pyrene 
LPO   lipid peroxidation 
MNE    Mean normalized expression 
MRM    Multi Reaction Monitoring 
MUFA   Monounsaturated fatty acid 
O&G   Oil and gas 
PAH   Polyaromatic hydrocarbons 
PCA    Principle Component Analysis 
PCB   Polychlorinated biphenyls 
PER    Perylene 
Phe   Phenanthrene  
PNL   Pseudo neutral loss scanning 
PUFA    Polyunsaturated fatty acid 
PY   Pyrene 
PW    Produced water 
qPCR   Quantitative real-time polymerase chain reaction   
RSD   Relative standard derivation 
SFA   Saturated fatty acid 
TAG   Triacylglycerol 
TLC   Thin layer Chromatography 
UHPLC MS/MS  ultra-high performance Liquid chromatography- tandem mass spectrometry 
XRE    Xenobiotic response element 
8-oxo-dG   8-Oxo-2'-deoxyguanosine 
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I. Introduction 
The objective of this project has been to study the formation of DNA damage in haddock 
(Melanogrammus aeglefinus) exposed to different petrogenic or pyrogenic polyaromatic 
hydrocarbons (PAHs). The main goal was to identify the sources of contaminants responsible for the 
DNA adducts observed in wild haddock caught around oil fields in the North Sea. This was achieved 
by studying the formation of DNA damage over time in haddock during chronic exposure for PAHs 
and other oil hydrocarbons. 
Juvenile haddock were exposed for two months through the diet with two different profiles of oil 
hydrocarbons, one containing mainly light two ring PAHs and one containing both light (3 ring) and 
heavy (4 ring) PAHs. In addition, a third group was exposed to a diet containing a mixture of heavy (4-
6 ring) PAHs, all treatments were compared with an unexposed control group. These groups 
represent exposure to either produced water, drilling mud or pyrogenic PAHs. After end of exposure,  
fish were followed for 2 months to measure long-term health effects or recovery. 
The main endpoint was analysis of DNA adducts (32P postlabelling), with a few additional samples 
analysed by different LC-MS methods as a pilot experiment to check the potential of this method to 
replace the non-specific 32P-postlabelling method.  
In addition, several others endpoints were analysed; bile metabolites, lipid composition, gene and 
protein expression and histopathology. All these measurements obtained from a controlled 
laboratory experiment support interpretation of the field survey results.  
Several key questions were addressed: 
1. Does oral exposure to PAH induce DNA-adducts in haddock? 
2. What is the time effect in DNA-adduct formation during chronic exposure, and how fast will 
fish recover? 
3. Does different PAH give different DNA adduct pattern from the 32P-postlabelling method, and 
can the “spot position” be used to identified the source of PAH exposure? 
4. How are DNA adducts correlated with other endpoints; PAH bile metabolites and CYP1A 
induction?    
 
1.1. Background 
Balk et al., (2011) reported that haddock caught in 2002 at the Tampen region of the North Sea had 
elevated levels of DNA adducts and responses in other biomarkers. This could be related to 
discharges from oil and gas (O&G) activity compared with haddock from a reference area (Egersund 
Bank, in the North Sea). This was the first time it has been reported that wild fish from the North Sea 
may be negatively affected by discharges from the offshore oil industry. Presence of DNA adducts in 
haddock from Tampen and the Viking Bank were later confirmed by the North Sea condition 
monitoring in 2005, 2008 and 2011 (Grøsvik et al. 2012). However, while the haddock from the O&G 
production areas have the highest levels of DNA adducts, the condition monitoring also found that 
haddock from the Egersund Bank had elevated levels of DNA adducts compared with more pristine 
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area like Iceland or the Barents Sea. This indicates that the whole North Sea has a general 
background contamination of PAH sufficiently high to create DNA damage in fish.  
 
The Tampen region is holding some of the main oil fields in the Norwegian and British sector of the 
North Sea, and there has been oil production in this region for more than 40 years. The Tampen 
region has several possible sources of oil pollution, including large deposits of oil contaminated 
cuttings around many of the sites (Breuer et al. 2004), and as the oil fields mature they produce 
more produced water (PW). The Tampen region contributes with approx. 60 % of the total discharges 
of PW from the Norwegian offshore oil fields. Other sources of PAH may be pyrolytic PAHs either 
from incomplete combustion of flaring from the platforms during well testing or from atmospheric 
input. Boitsov et al. (2013) showed that the North Sea sediments contains a general background level 
of manly pyrogenic PAHs (Boitsov et al. 2013). 
 
PAH composition is connected to the original sources. Petrogenic PAHs are dominated by 2 and 3 ring 
PAHs and have a large contribution of alkylated isomers, while the pyrogenic PAHs are dominated by 
high molecular PAHs (≥4 rings PAHs) and low levels of alkylated PAHs. PW contains mostly 2 ring 
PAHs (≈90 %) and only very low concentration of heavy PAH, where the oil used in oil-based drilling 
mud also has a small contribution of 4 rings PAHs (2%). However, during weathering and 
sedimentation processes the petrogenic PAHs also changes profile in the marine environment 
towards relatively more heavy PAHs, and the PAH profile found in old drill cuttings under platforms 
from the Tampen area typically contain some 4 ring PAH (9 %) and 5 ring PAH (3%) (Table 1). 
 
Table 1. PAH composition (%) in base oil (HDF200), produced water from Gullfaks and sediments from the 
North Sea. Sediment has been sampled from old drill cuttings, Sediment G-16 is from the same platform area, 
but sampled from the periphery of the deposited drill cuttings. The sediment from Skagerrak shows the 
maximum background levels of PAH in the North Sea.  
2.  
3.  
 
Some PAHs are known to be carcinogenic as they are metabolized into reactive intermediates that 
can bind covalently to DNA. The formation of PAH-DNA adducts has been connected to induction of 
mutations and development of tumours and cancer. The formation of PAH-DNA adducts is strongly 
dependent on PAH structure the and the ability to produce reactive electrophilic metabolites. There 
are several proposed metabolic pathways that can activate PAHs; the dihydrodiol epoxide pathway, 
the ortho-quinone pathway, the radical cation pathway and the arylmethyl carbocation pathway 
(details are given in (Bostrom et al. 2002; Flesher and Lehner 2016; Xue and Warshawsky 2005)).  
The dihydrodiol epoxide pathway is considered as the most important, and it is generally found that 
only PAH with at least 4 rings and either “bay” or “fjord” like structures have the capability to be 
metabolized to the mutagenic diol epoxide (DE) (Figure 1). The activation of the PAH goes through 
ligand binding to the aryl hydrogen receptor (AhR) and induction of the cytochrome P450 
detoxification system. The DE pathway for formation of DNA-adducts is well described for the highly 
carcinogenic, benzo(a)pyrene (BaP) (Bostrom et al. 2002), however, although phenanthrene (Phe) 
HDF 200 oil Gullfaks (PW) Sediment (G-10) Sediment (G16) Sediment Skagerrak
PAH concentration 0,76 g/kg (0,08 %) 923 µg/l 40143 µg/kg 4739 µg/kg 6313 µg/kg
∑2 rings 84,0 88,4 62,4 43,7 11,6
∑3 rings 13,7 11,1 25,8 49,6 17,8
∑4 rings 2,3 0,4 8,9 4,6 12,1
∑≥5 rings 0,0 0,2 2,9 2,1 58,5
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can be metabolized into DE compounds, it is not been found to be carcinogenic (Carmella et al. 
2004).  
Flesher and Lehner (2016) are the founders of the “Unified theory” that provides a mechanistic 
explanation (the arylmethyl carbocation pathway) of why some methylated PAHs are much more 
potent carcinogens that the non-methylated parent PAHs (Flesher and Lehner 2016). Benzylic 
hydroxylation followed by sulphation can results in highly reactive esters which can form benzyl DNA 
adducts (Bendadani et al. 2014;Flesher et al. 1997)   
4.  
5.    
6.  
7.   
8.  
9.  
Figure 1. Metabolism of benzo[a]pyren (BaP) and phenanthrene (Phe) to bay region diol epoxides (BPDE and 
anti-PheDE) and tetraols (trans, anti-BaP-tetraol and trans, antiPheT), and metabolism of phenanthrene to 
phenanthrols (1-HOPhe, 2-HOPhe, 3-HOPhe, 4-HOPhe and 9-HOPhe (Camella et al., 2004)  
There are several reports showing that exposure of crude oil and PW can induce DNA adducts in 
marine fish, both from laboratory studies (Aas et al. 2000a;Holth et al. 2009;Lyons et al. 1997;Sundt 
et al. 2012) and field observations after major oil spills (Amat et al. 2006;Harvey et al. 1999). 
Likewise, in vitro studies showed that oils and oil fractions contain genotoxic compounds that induce 
DNA adducts (Akkineni et al. 2001;Ingram et al. 2000;Nagy et al. 2004). However, the genotoxic 
compounds in crude oil have not been identified yet. 
Alkylated three rings PAH may be candidates for oil compounds that can induce DNA adducts, as it 
has been shown that some dimethylphenanthrenes are potent tumor inducers in mice, while 
methylphenanthrene and non-methylated 2 and 3 rings PAH are not genotoxic (Lavoie et al. 
1981;Lavoie et al. 1982) 
Alkylated PAHs are metabolised either by hydroxylation of the aromatic ring or at the alkyl chain 
(Lavoie et al. 1981). Malmquist et al., (2013, 2015) shows that polycyclic aromatic acids are the 
dominating metabolites from alkylated phenanthrene, pyrene and chrysene in a marine benthic 
invertebrate (Nereis diversiocolor) (Malmquist et al. 2013;Malmquist et al. 2015). The degradation 
pathway suggested by Malmquist et al., goes through multi-step oxidation of the alkyl chain, starting 
with benzylic hydroxylation (-CH2OH), further to aldehyde (-CHO) and to carboxylic acid (-COOH). 
These phase I metabolites are conjugated to amino acids (glucine), glucoronide or sulfate (Figure 2). 
Similar degradation pattern are also found in soil fungus (Cunninghamella elegans) (Boll et al. 2015) 
and bacteria (Pseudomonas Putida) (Mahajan et al. 1994). It is likely that similar metabolic pathways 
will also exist in fish, and together with the possibility of formation benzyl DNA adducts, one should 
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therefore look more into whether alkylated PAHs in crude oil are responsible for the DNA adduct 
formation found in wild fish in the North Sea. 
Phase one Phase two
 
Figure 2. Biotransformation of 1-methylpyrene proposed by Malmquist et al., based by metabolites identified 
in Neries diversiocolor (letters) or found in the literature (*). The figure is modified from (Malmquist et al. 2013) 
 
Figure 3. Autoradiogram from 32P-postlabelling analyses of Atlantic cod exposed 30 days in the laboratory for 1 
mg crude oil /l (Aas et al., 2000) and wild haddock caught in the North Sea (Balk et al. 2011). All the black dots 
represent different DNA adducts. 
A challenge for interpretation of DNA adduct results is that the preferred analytical methods, the 32P-
postlabelling assay (Phillips 2013), does not provide structural information for identification of 
unknown adducts. It is therefore not possible to identify which PAHs (or other compounds) are 
responsible for the formation of DNA adducts in complex exposures like crude oil/PW (Figure 3). To 
overcome this challenge, a large effort has been put into the development of new mass spectrometry 
based methods for identification of DNA adducts (Klaene et al. 2013;Singh and Farmer 
2006;Tretyakova et al. 2013). Secondary goals of this project are to generate samples with high levels 
of PAH DNA-adducts which can be used in a planned future project with these new methods in 
attempt to identify major DNA-adducts generated in haddock during PAH exposure, and to create 
mass spectra libraries that can be used for comparison in future field studies.   
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In addition to the focus on DNA adducts have we also studied different biological mechanisms/gene 
pathways that are known to be affected by oil pollution by characterizing genome-wide gene 
expression profiles (RNA-Seq). Special attention was given to genes involved in the cytochrome P450 
detoxification system, the oxidative defence systems, and the DNA repair system.  
Other exposure biomarkers, like liver content of PAH, PAH bile metabolites, liver lipid profiles and 
liver proteins (CYP1A), have also been measured to evaluate possible physiological consequences 
related to DNA adduct formation. After the end of the two-month exposure, some of the fish were 
followed for 2 months to evaluate if the PAH exposure affected long term growth and survival. These 
fish were examined by histopathologic methods to investigate whether DNA-adducts correlated with 
changes at cellular levels (neoplasia or other non-neoplastic lesions). 
II. Experimental set up 
The exposure experiment started 14th February and lasted till 22th April, 2014. A group of fish were 
kept for two months until 19th June to look for long-term effects. The exposure experiment has been 
conducted as planned and we have sampled 420 haddock. 
2.1. Exposure regime 
We exposed haddock for three different PAH profiles that represented different possible PAH 
sources that can be present in the North Sea; produced water (PW), oil based cutting pile (deposited 
before 1993) and sediments from assumed reference areas.  
Table 2 and Table A1 give an overview of the PAH composition (%) in produced water from Statfjord 
A and sediments from old drill cuttings sampled either just under the platform or at short distance 
from the main cutting pile.  The sediment from the deeper part of Skagerrak shows the maximum 
background levels of PAH in the North Sea.  
Table 2. PAH profiles (%) and concentration (mg/L or mg/kg) in produced water and sediments from the North 
Sea. 
 
 
 
 
 
Clear differences in PAH composition have been identified, PW is dominated by 2 ringed PAHs (>90 
%) with a small fraction of 3 ringed PAHs, but only very low amount of heavy PAHs (≥4 ringed PAH). 
The drilling mud sediments also contain high levels of 2 ringed PAHs (44-62 %), but have in addition 
high amount of 3 ringed PAHs (26-50 %) and some heavy PAHs (≥4 ringed PAH). The background 
sediments are dominated by heavy PAHs (≥4 ringed PAH).  
PAH profile (%)
Produced water 
(Statfjord A)
Old drill mud 
(under Statfjord A)
Old drill mud (close 
to Statfjord A))
Marine Sediment 
(Skagerrak)
∑2 rings PAH 91.1 62.4 43.7 11.6
∑3 rings PAH 8.7 25.8 49.6 17.8
∑4 rings PAH 0.2 8.9 4.6 12.1
∑5 rings PAH 0.0 2.8 1.3 40.0
∑6 rings PAH 0.0 0.1 0.8 18.5
PAH concentration 3.5 mg/l 40 mg/kg 5 mg/kg 6 mg/kg
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Both PW and drilling mud sediments have high amount of 2 ringed PAH. However, we did not wish to 
have too large overlaps in PAH compositions between the different exposure groups. Therefore, we 
did not mimic the PAH profiles in the sediments exactly, but tried to make exposures that were 
representative for the dominating PAHs from the different sources: 2 ringed PAHs (PW), 3 ringed 
PAHs (oil containing sediment) and 4-6 ringed PAHs (background sediments) (Figure 4, Table 3).    
 
Figure 4/Table 3. PAH profiles in the three exposure feeds. Analysed by GC-MS. 
Table 4. Distribution of heavy PAHs in the “PAH feed”. Classification of carcinogenicity from the International 
Agency for Research on Cancer (WHO-IARC, 2010). Group1: carcinogen to humans; Group 2A: probably 
carcinogen to humans; Group2B: possibly carcinogen to humans; Group3: not classifiable as to carcinogenicity 
to humans. 
Compounds Number of rings MW Distribution in the food (%) IARC Group DNA adducts potential
Fluoranthene 4 202 5 3  -
Pyrene 4 202 4 3  -
Benz(a)anthracene 4 228 3 2B  ++
Chrysene 4 228 4 2B  ++
Benzo(b)fluoranthene 5 252 13 2B  +
Benzo(k)fluoranthene 5 252 12 2B  +
Benzo(e)pyrene 5 252 5 3   + 
Benzo(a)pyrene 5 252 6 1  +++
Perylene 5 252 2 3  -
Dibenz(a,h)anthracene 5 278 19 2A  +++
Indeno(1,2,3-cd)pyrene 6 276 22 2B  - 
Benzo(ghi)perylene 6 276 4 3  -  
2.2 Fish and exposure 
The experiment was carried out on juvenile haddock (100-250 g) and the fish were exposed to 
different hydrocarbon mixtures through the feed. The fish were marked with electronic tags and held 
in five circular tanks (3 m diameter, 7 m3). The fish were dosed with automatic feeding unit 5 times a 
week with a ratio corresponding 10 g pellets/kg fish/day (1 % of body mass per day). The PAH 
concentration in the pellets was from 31-65 mg/kg (table 3) and this correspond a daily dose of PW 
treatment group: 0.31 mg PAH/kg; Oil treatment group: 0.45 mg PAH/kg and PAH treatment group: 
0.65 mg PAH/kg. (Detail about the exposure diet is giving in the appendix; Material and Methods). 
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The exposure experiment started 14th February and ended 22th April. Samples were taken one week 
after end of exposure and the remaining fish were transferred to one common tank and maintained 
for two months until 19th June in order to study long term effects.  
At the start of the experiment 26 haddock were injected with single a PAH compound (2 fish for each 
of the 12 heavy 4, 5 and 6 ringed PAH compounds used in the PAH mixture) and sampled after two 
days. The PAHs were dissolved in dimethyl sulfoxide (DMSO) and fish oil to a concentration of 4 
mg/ml. Each fish was injected in the abdominal cavity with 1 µl/g fish, corresponding to a dose of 4 
mg/kg fish. The injected fish will be used to generate a bile metabolite and DNA adduct “library”.  
2.3 Sampling 
Six samplings of fish were performed during the experiment (Table 5). The first sampling was done 3 
days after the first oral dose or injection. 
Table 5. Sampling time and number of fish. 
 
 
 
Samples were taken of several tissues (blood, bile, liver, muscle, brain, intestine, heart and whole 
fish) (Table M3). The samples of intestine, heart and brain will not be included in the analytical 
program of this application. The material will be kept at IMR for future studies. 
 
III. Results 
3.1 Exposure and appetite 
The first observation after 2 and 10 days of exposure showed that the fish from the exposure groups 
had lower appetite than the control fish. Less food was found in the stomach of these fish and the 
growth was negative for many fish. This was most likely a result of reduced appetite because the fish 
sensed the oil compounds. To reduce the “smell” of the oil compounds, the pellets were mixed with 
a “paste” made of homogenized prawns before each feeding. This had an immediate positive effect 
on the appetite of all haddock groups and from the daily observations of feeding we registered that 
all groups were eating the pellets after we started to use prawn pasta. 
3.1.2 Growth 
All fish increased their weight at the third sampling point (five weeks after exposure). The PAH 
exposure group, however, had significant lower weight and growth rate (0.4 % daily growth factor) 
compared with the control fish (1 % daily growth factor). During recovery, some increase in the 
growth factor was observed in the PAH exposure group (up to 0.7 % growth a day), but there was a 
clearly reduced growth in the fish fed pellets contaminated with heavy PAHs. This is probably mainly 
Exposure groups 17.02.2014 24.02.2014 24.03.2014 22.04.2014 29.04.2014 19.06.2014
Control 10 10 15 20 10 36
PW 10 10 15 20 10 35
Oil 10 10 15 20 10 31
PAH 10 10 15 20 10 33
Injection (PAH) 25
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due to reduced appetite in this group, but increased metabolic cost associated with detoxification of 
PAH may also contribute. 
After 2 months of recovery, the oil-exposure group was also found to have lower growth compared 
with control, while the PW fish did not differ from the control group.  
Reduced growth after oral exposure of PAHs and crude oil have been reported in several fish species; 
Zebrafish (Danio rerio) had reduced growth in all three exposure groups (sediment extract=heavy 
PAHs), heavy oil extract and light oil extracts) receiving 9 months with 4.6-6.7 mg PAH/kg feed 
(Vignet et al. 2014), reduced growth in Rockfish (Sebastes schlegeli) exposed for BaP (1.5 and 2 mg 
BaP/kg feed) in 30 days; 6 week oral exposure for water-accommodated-fraction (WAF) of heavy oil 
(2.2 mg WAF/kg feed) gave growth reduction in juvenile turbot (Scophthalmus maximus) (Saborido-
Rey et al. 2007); juvenile Chinook salmon (Oncorhynchus tshawytscha) feeded pellets that mimic PAH 
exposure from urban estuaries had reduced weight after 53 day at doses of 22 mg PAH/kg fish 
(Meador et al. 2006). 
Table 6. Length, weight, liver weight, hepatosomatic index, condition factor and daily growth factor (weight 
increased relative to exposure start 14.02) for all treatment groups.  Sampling under “grey” labels are during 
exposure and under “brown” labels are during recovery. Asterisks indicate statistical significance from the 
control fish (*p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17.02.2014 (n) Lenght (mm) Weight (g) Liver weight (g) HSI Condition factor Daily growth factor (%)
Kar 22 Control 10 225 ± 18 141 ± 28 22 ± 7 15 ± 2 1.23 ± 0.2 -0.2 ± 1.3
Kar 23 PW 10 228 ± 12 164 ± 37 25 ± 9 15 ± 3 1.36 ± 0.1 -0.1 ± 0.7
Kar 24 Oil 10 230 ± 8 167 ± 32 29 ± 6* 17 ± 1* 1.35 ± 0.1 -1.2 ± 1.5
Kar 25 PAH 10 226 ± 7 147 ± 15 20 ± 4 14 ± 1 1.26 ± 0.0 -0.2 ± 0.7
24.02.2014 (n) Lenght (mm) Weight (g) Liver weight (g) HSI Condition factor Daily growth factor (%)
Kar 22 Control 10 230 ± 19 140 ± 31 21 ± 6 15 ± 2 1.15 ± 0.2 0.6 ± 1.4
Kar 23 PW 10 228 ± 13 154 ± 33 24 ± 7 16 ± 2 1.29 ± 0.1 0.0 ± 0.2
Kar 24 Oil 10 235 ± 12 162 ± 31 28 ± 7* 17 ± 2* 1.23 ± 0.1 -0.2 ± 0.3
Kar 25 PAH 10 229 ± 15 166 ± 35 29 ± 7* 18 ± 2* 1.40 ± 0.4 -0.7 ± 0.3*
24.03.2014 (n) Lenght (mm) Weight (g) Liver weight (g) HSI Condition factor Daily growth factor (%)
Kar 22 Control 15 236 ± 18 180 ± 46 30 ± 9 17 ± 2 1.35 ± 0.1 0.9 ± 0.5
Kar 23 PW 15 241 ± 15 193 ± 37 35 ± 9 18 ± 3 1.37 ± 0.1 0.7 ± 0.2
Kar 24 Oil 15 239 ± 15 180 ± 34 32 ± 8 17 ± 2 1.31 ± 0.1 0.6 ± 0.1*
Kar 25 PAH 15 244 ± 19 191 ± 47 33 ± 9 17 ± 2 1.30 ± 0.1 0.4 ± 0.2*
22.04.2014 (n) Lenght (mm) Weight (g) Liver weight (g) HSI Condition factor Daily growth factor (%)
Kar 22 Control 20 260 ± 13 233 ± 43 41 ± 9 17 ± 2 1.32 ± 0.1 1.0 ± 0.4
Kar 23 PW 20 261 ± 16 248 ± 50 45 ± 11 18 ± 2 1.38 ± 0.1 0.8 ± 0.2
Kar 24 Oil 20 251 ± 19 206 ± 65 36 ± 17 17 ± 4 1.26 ± 0.2 0.8 ± 0.3
Kar 25 PAH 20 247 ± 18* 183 ± 46* 34 ± 9* 19 ± 4 1.19 ± 0.1* 0.4 ± 0.3*
29.04.2014 (n) Lenght (mm) Weight (g) Liver weight (g) HSI Condition factor Daily growth factor (%)
Kar 22 Control 10 268 ± 17 265 ± 59 48 ± 13 18 ± 3 1.36 ± 0.1 0.9 ± 0.3
Kar 23 PW 10 252 ± 16 235 ± 62 39 ± 15 16 ± 3 1.40 ± 0.1 1.0 ± 0.3
Kar 24 Oil 10 261 ± 15 254 ± 42 42 ± 7 17 ± 2 1.47 ± 0.3 0.7 ± 0.2
Kar 25 PAH 10 256 ± 13 205 ± 39* 32 ± 10* 16 ± 3 1.21 ± 0.1* 0.4 ± 0.2*
19.06.2014 (n) Lenght (mm) Weight (g) Liver weight (g) HSI Condition factor Daily growth factor (%)
Kar 22 Control 36 289 ± 17 336 ± 57 62 ± 14 18 ± 3 1.39 ± 0.2 1.1 ± 0.4
Kar 23 PW 35 281 ± 21 299 ± 85* 51 ± 19* 17 ± 2* 1.31 ± 0.1 1.1 ± 0.5
Kar 24 Oil 31 278 ± 20* 292 ± 75* 51 ± 15* 17 ± 3 1.33 ± 0.1 0.8 ± 0.5*
Kar 25 PAH 33 263 ± 21* 236 ± 69* 41 ± 16* 16 ± 5 1.26 ± 0.2* 0.7 ± 0.5*
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Figure 5. Weight (A) and daily growth factor (B) for all treatments groups and samplings points. Data presented 
as average ± stdev. 
 
Analytical program 
The main aim of this project is to study the formation of DNA damage over time in haddock during 
chronic exposure for different sources of PAHs. However, there are several other parameters that are 
relevant regarding interpretation of the results of the last years’ water column monitoring survey. 
These include bile metabolites, lipid composition, gene and protein expression and histopathology.  
 
3.3 DNA adducts 
To study the formation of DNA adducts over time, DNA from liver samples were analyzed by the 32P- 
postlabelling methods after 3, 35 and 67 days exposure, and again after 7 and 58 days of recovery. 
The analyses were done by ADn’tox laboratory in France. This is the same laboratory that has been 
used in the water column monitoring program, and the results can be compared with results from 
earlier field studies. 
 14 
 
3.3.1 Fish injected with heavy PAHs  
The 32P-postlabelling analysis of fish injected with a high dose (4 mg/kg body burden) of a single 
compound of heavy PAHs shows that 3 compounds did not induce DNA adducts (FL, PY, IND), 5 
compounds had detectable but low levels of DNA adducts (BEP, BBF, BKF, PER, BP), while 4 
compounds had very high levels of DNA adduct (BAA, BAP, C, DBA). The 2 replicates showed that 
there was large variation in intensity for several compounds (RSD from 6-130 %), but the pattern 
regarding none, low or high formation of DNA adduct were stable (figure3 6 and 7). 
Fluoranthene (FL)
Pyrene (Py)
Benz(a)anthracene (BAA)
Chrysene (C)
Benzo(b)fluoranthene (BBF)
Benzo(k)fluoranthene (BKF)
 
Benzo(e)pyrene (BEP)
Benzo(a)pyrene (BAP)
Perylene (PER)
Dibenz(a,h)anthracene (DBA)
Indeno(1,2,3-cd)pyrene (IND)
Benzo(ghi)perylene (BP)
 
Figure 6. Individual autoradiogram of 12 heavy PAHs (4-6 rings). Fish injected with 4 mg/kg of single 
compounds (2 replicates for each compound) and sampled after three days.  
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The response in haddock fits well with the literature from in vitro studies, where FL, PY and IND do 
not induce DNA adducts and are classified as non-carcinogenic (Audebert et al. 2012;Tarantini et al. 
2011) and the 4 high inducers, BAA, BAP, C and DBA are all known to be potent in inducing DNA 
adducts, and being carcinogenic or possible carcinogenic PAHs (WHO-IARC, 2010, Audebert et al., 
2012). Of the 5 low inducers, several of them are suspected to be carcinogenic, but they are not very 
potent to induce DNA adducts (Audebert et al. 2012;Ericson et al. 1999;Platt et al. 2008;Tarantini et 
al. 2011)   
 
Figure 7. DNA adducts in the liver of fish injected with heavy PAH (4-6 rings) (2 replicates of each compound, 
exept chrysene). Data presented as average ± stdev. 
The results from the injected fish showed that haddock responded quickly to intraperitoneal 
injection of PAHs and high amounts of DNA adducts were detected 3 days after injection.  
3.3.2 Oral exposure of Haddock 
Increased levels of DNA adducts compared with control fish were found in all treatment groups 
(control 0.15±0.07; PW 14.2±0.4; Oil 40; PAH 122±133 nmol adducts/mol normal DNA) (Figures 8 and 
9). This shows that PAHs from all the different treatments groups are taken up from the food and 
readily metabolised to reactive metabolites that bind the DNA in the liver, and that a single oral dose 
is sufficent to induce DNA adducts 3 days after exposure. The exposure for heavy 4-6 rings PAHs 
results in a strong induction of DNA adducts that quantitative were in the same ranges as the 
injected fish. However, there were large variation between the two replicates (27 and 216 nmol 
adducts/mol normal DNA), which may reflect differences in how much food the indivudual fish 
consumed. However, as seen from the injected fish there can also be very large variation in the DNA 
adduct induction responses between fish (Figure 8 and 9). Also, the oil exposed fish had higher levels 
of DNA adducts compared with the  PW exposed  group.  
Due to uncertainties with regard to how much the fish had been eating during the first feeding, we 
did only send two samples (as a test) for DNA adducts analyses. As shown from the presented results 
it was unfortunate that we did not analyze a higher number of samples per group to be able to 
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perform statsitical analyses.  These samples are stored at –80C freezer and may be considered to be 
analysed later. Likevise we did not prioitise to analyse the fish sampled after 10 days exposure. It 
would be interesting to analyse these to get a better understanding of the time response after oral 
exposures.  
  
Figure 8. Autoradiograms of control, PW, Oil and PAH treated fish. Fish were sampled three days after the first 
oral exposure dose. Only two samples per group were selected for DNA adduct analysis. These fish were 
selected at “eaters” from the presence of faeces in the intestine. 
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Figure 9. DNA adduct in the liver of fish from the different treatment groups three days after one oral dose. 
Data presented as average ± stdev. 
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Long-term exposure for 37 and 67 days also resulted in significant elevated levels of DNA adducts in 
all treatments groups compared with controls (Control: 0.3±0.5 and 1.9±2.5, PW: 3±2 and 8±9 nmol 
adducts/mol normal DNA nmol adducts/mol normal DNA, Oil: 4±2 and 4±4, PAH: 8±3 and 11±11 
nmol adducts/mol normal DNA) (figure 11). However, the DNA adduct levels were considerably lower 
(nearly 10 times) compared with the single dose and 3 days’ exposure. Any clear decline in the levels 
of DNA adducts were not seen after the recovery period, and after 58 days’ recovery all three 
treatment groups had higher DNA adducts levels (6.7-10.5 nmol adducts/mol normal DNA) than the 
control group (1.2 nmol adducts/mol normal DNA). 
Table 7 show a selection of exposure studies that measured DNA adduct in marine fish. Aas (2000) 
studied DNA adduct formation in Atlantic cod (Gadus morhua) exposed for crude oil through the 
water (0.06-1 mg oil/l = 0.33-7.8 µg PAH/l), and they found an induction of liver DNA adducts (11±4 
nmol adducts/mol normal DNA) after 3 days exposure in the high exposure group, and DNA adduct 
levels were constantlyduring the 30 day experiment, peaking at 109±45 nmol adducts/mol normal 
DNA. Seven days in clean water did not show any decline and recovery in the DNA adduct levels. The 
low doses of oil (0.33µg PAH/l) also showed elevated DNA levels (4±2 nmol adduct/mol normal DNA) 
after 30 days exposure (Aas et al. 2000a). In a similar 14 days water exposure study with crude oil (1 
mg oil/l) on cod and polar cod (Boreogadus saida) the same research group did only find medium 
induction of DNA adducts 18±11 and 12±4 nmol adduct/mol normal DNA respectely (Aas et al. 2003). 
Long-term water exposure (16-44 weeks) of cod to artificial PW (5.4 µg PAH/l + 11.4 µg 
alkylphenols/l) showed medium DNA adduct levels (9 nmol adduct/mol normal DNA) after 16 weeks’ 
exposure, but high induction of DNA adducts after 44 weeks (73 nmol adduct/mol normal DNA) 
(Holth et al. 2009). Cod exposure for Ekofish PW for 28 days had low but significant induction of DNA 
adducts in 0.25 % PW (1.7±0.9 nmol adduct/mol normal DNA) and 0.5 % PW (4.4±2.4 nmol 
adduct/mol normal DNA) (Sundt et al. 2012). 
Table 8 shows DNA adduct levels in wild haddock caught in pristine sea areas outside Island and in 
the Barents Sea and the North Sea (Egersund Bank and the Tampen area). The DNA adduct levels in 
pristine area were 0.6-0.7 nmol adducts/mol normal DNA, at the references area of the North Sea 
0.6-5.5 nmol adducts/mol normal DNA and at the Tampen area 1.7-11 nmol adducts/mol normal 
DNA. 
The levels of DNA adducts found from oral exposure in the present experiment can only be 
considered as highly induced at the first sampling point after 3 days of exposure. After chronical long-
term exposure the DNA adduct levels were only slightly induced and in the ranges of what have been 
reported in wild caught haddock from the North Sea and in experimental studies with high dose of 
PW. These observed levels of DNA adducts after chronic exposures were surprising, and suggested an 
adaption during long term oral exposure, either by induced clearance rate in the intestine and 
thereby lower uptake to the liver, or by induction of the DNA damage repair system. 
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Figure 10. Individual autoradiograms of control, PW, Oil and PAH treated groups after 67 days of oral exposure 
(sampled 22.04.2014). Two plots from each group are shown, the highest induced fish and the lowest induced 
fish. 
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Figure 11. DNA adducts in the liver of fish from the different treatments groups after (A) 37 days and (B) 67 
days of oral exposure or (C) 7 days and (D) 48 days of recovery with clean food (n=10). Data presented as 
average ± stdev. (*) and (**) indicate significant differences compared with control, p< 0.05 or p<0.01. 
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Table 7. DNA adducts data from experimental exposure (crude oil and PW) studies using water exposure. 
Species Treatment dose and exposure time 
DNA adduct level 
(nmol/mol normal 
DNA) 
Referances 
Cod  0.04 mg oil/l (0.33 µg PAH/ l) for 30 days 4±2 (Aas et al. 2000a) 
0.14 mg oil/l (1.14 µg PAH/l) for 30 days 11±4  
0.94 mg oil/l (7.8 µg PAH/ l) for 3 days 11±4  
0.94 mg oil/l (7.8 µg PAH/ l) for 16 days 64±15  
 0.94 mg oil/l (7.8 µg PAH/ l) for 30 days 109±45  
Cod Control 1.6±1.1 (Aas et al. 2003) 
 1 mg oil/l for 14 days 18±11  
Polar cod  Control 1.2±0.5 (Aas et al. 2003) 
1 mg oil/l for 14 days 12±4  
Cod Control 0.5±0.3 (Sundt et al. 2012) 
 0.125 % PW for 28 days 2.0±1.6  
 0. 25 % PW for 28 days 1.7±0.9  
 0.5 % PW for 28 days 4.4±2.4  
Cod Control, 16 and 44 weeks <1,26-2 (Holth et al. 2009) 
 Artificial PW; 0.54 µg PAH/l + 1.14 µg 
alkylphenols/l for 16-44 weeks 
2-7  
 Artificial PW; 5.4 µg PAH/l + 11.4 µg 
alkylphenols/l for 16-44 weeks 
9-73  
 
Table 8. DNA adducts data in haddock from field sampling 2002-2011. 
Area 
DNA adduct levels (nmol adduct/mol 
normal DNA) Ref 
Iceland 2002 0.6±0.4 (Balk et al. 2011)  
Barents Sea 2008 0.7±0.4 (Grøsvik et al. 2009)  
Egersund Bank 2002 4.0±3.2 (Balk et al. 2011)  
Egersund Bank 2005 2.1±1.4 (Grøsvik et al. 2007)  
Egersund Bank 2008 0.6±0.3 (Grøsvik et al. 2009)  
Egersund Bank 2011 5.5±7.1 (Grøsvik et al. 2012)  
Tampen 2002 19±11 (Balk et al. 2011)  
Tampen 2005 4.4±4.4 (Grøsvik et al. 2007)  
Tampen 2008 1.7±2.1 (Grøsvik et al. 2009)  
Tampen 2011 7.3±5.6 (Grøsvik et al. 2012)  
 
In all groups some individual fish had no detectable levels of DNA adducts, this may either be a result 
of differences in how much each fish had been eating and been exposed to, or it may be result of 
differences in the metabolic capacity of the individual fish (Figure 12). Typically, low but detectable 
levels of DNA adducts were measured in 50 % of the control fish. The PAH content of the food was 
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analysed by GC-MS (Figure 19) and contamination of the control food was not detected. This 
suggests that DNA adducts in haddock are quite common in many fish. The presence of endogenous 
DNA adducts in haddock have also been suggested from the water column monitoring of wild fish 
(Balk et al. 2011). The position of the DNA adduct spots in the TLC plate from the control fish are 
similar as for the exposed fish. It is therefore not possible to exclude false positive of endogenous 
DNA adducts. 
 
Figure 12. Frequence of samples with undetectable amount of DNA adducts (blue column >0.1 nmol 
adduct/mol normal DNA) and DNA adduct levels higher than 4 nmol adduct/mol normal DNA (red column). 
(***) indicate highly significant differences of the occurrence of samples without detectable compared with 
control at all sampling points, (p<0.0001, Cochran-Mantel-Haenszel test) and samples with elevated DNA 
aducts levels (>4 nmol adduct/mol normal DNA) (P<0,0001). 
 
3.3.3 Autoradiogram TLC maps 
One main objective of this investigation was to investigate if different PAH sources gave different 
DNA adduct pattern on the 32P-postlabelling TLC plates, and whether the spot position could be used 
to identify the sources of PAH exposure. Figure 13 shows the difference spot position of the heavy 
PAH single compounds and the three oral mixtures. 
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Chrysene (C) Benzo(b)fluoranthene (BBF) Benzo(k)fluoranthene (BKF) Benz(a)anthracene (BAA)
Benzo(e)pyrene (BEP) Benzo(a)pyrene (BAP) Benzo(ghi)perylene (BP)Dibenz(a,h)anthracene (DBA)
PW
Oral
Oil
Oral
PAH
Oral
 
 
Figure 13. Autoradiogram of TLC maps in liver of haddock injected with single PAHs or exposed orally for 
mixtures of PAHs (PW, Oil, PAH). The lower plot show overlap maps of the TLC spots from the different injected 
single compounds and the oral mixtures. 16 different spots from all the 384 plates (192 samples) analyzed in 
this project were identified.  
There are clear differences in the numbers of DNA adducts detected on the TLC plates, with BaP 
giving rise to at least 5 different spots while BP treatment only shows one spot. There are some 
differences in position of the spots from the difference PAHs, however, the main picture is that there 
is a strong overlap between all compounds and no unique TLC pattern was seen. Similarities in the 
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pattern of spots between most PAH were seen, with a big spot in the middle of the plate (spot1) and 
several smaller spots in the upper right corner (spot 2, 3 and 4). No major spot with high intensity 
appeared to be specific to one single PAH compound. Spots 7, 8 and 9 are only observed in fish 
exposed to BAP. Spots 12, 14 and 15 are only observed in fish exposed to DBA. Spot 13 is only 
observed in the liver of one fish exposed to BEP. (Figure 13). 
The patterns in the oral exposed groups were not that diverse compared to the single PAH injected 
groups. Three spots were found in more than 10 % of all the samples, spot1, spot3 and spot5. Table 7 
show that there was a clear increased presence of the DNA adducts in the exposed groups (PAH 
group>Oil group>PW group>>control). However, it was not possible to distinguish between the three 
different PAH sources from the oral exposed groups using the TLC spot pattern. 
Table 7. Frequencies of the total number of samples in each treatment groups with detectable levels of the 
three dominating spots (1,3 and 5).  
  
Control 
group 
PW 
group 
Oil 
group 
PAH 
group 
Chi-square 
test 
Spot1 21% 50% 66% 81% P<0.0001 
Spot3 0% 14% 19% 26% P=0.007 
Spot5 17% 40% 48% 49% P=0.008 
 
This confirms the limitation of the 32P-postlabelling assay to give structural information of the 
different DNA adducts and thereby the identity of the PAH metabolites that are causing the DNA 
damage.  
The 32P-postlabelling assay is the preferred analytical method for studying DNA adducts because of 
its very high sensitivity (Phillips 2013). However, a major drawback of this method is the very limited 
capacity to identify which PAHs (or other compounds) are responsible for the formation of DNA 
adducts. This is especially the case for the water column survey where we are working with wild fish. 
During the last decade, several groups have aimed to develope mass spectrometric methods for DNA 
adducts analysis (Himmelstein et al. 2009;Singh and Farmer 2006).  However, a important challenge 
has been to get analytical platforms that could work with the extreme low detection limits needed (1 
adducts per 109 unmodified DNA bases). New developments in LC-MS technology have made 
possible the necessary demands for sensitivity, and a significant effort has been put into the 
development of new mass spectrometry based methods for identification of DNA adducts (Balbo et 
al. 2014;Klaene et al. 2013;Monien et al. 2015;Tretyakova et al. 2013). There are still several 
challenges in optimizations of the methods (Klaene et al. 2016) and there is a large need of making 
more standards of DNA adducts (preferably isotope marked) that can be used for confirmation of 
chromatography and mass spectra identity and to make quantitative assays. However, there is broad 
agreement in the literature that development of LC-MS methods are necessary to be able to study 
details in DNA-adduct formations. 
In this project a small pilot study with LC-MS analysis was performed. Two samples (after month 
exposure) were selected for UHPLC-MS/MS, one from the PAH exposed group and one control.  
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The samples were analysed on UHPLC-MS/MS with several different scan methods; 
Test 1: Target multiple reaction monitoring (MRM) for the known BAP DNA-adduct, dG-N-2-BPDE. 
Test 2: Non target pseudo neutral loss scanning (PNL). This is a screening method looking for 
“unknown” DNA adducts. 
 
The results are giving in the appendix. It suggests that the haddock do not produce the known BAP 
DNA-adduct, dG-N-2-BPDE, but instead are there found several other peaks in the exposed fish and 
the MS spectra suggests DNA adducts that contains nitrogen atom (in NH2 or NO2 functions). It 
remains to get a positive identification through analysing standards, but it shows that the LC-MS/MS 
is sensitive enough to detect DNA adducts in this samples. 
 
3.4 Bile metabolites 
Analyses of hydroxylated PAH metabolites in the bile is a well establish biomarker for exposure to oil 
and PAH exposure. Two different methods have been used, GC-MS of single compounds (22.04) and 
Fixed wavelength fluorescence analysis (23.03, 22.04 and 29.04) (FF method).  
The GC-MS quantify 22 standards (2 naphthol, 10 methyl-naphthol, 2 hydroxyfluorene, 6 
hydroxyphenanthrene and 1-hydroxypyrene and 2-hydroxychrysene), the results are given as the 
sum of all standards.  
The fixed wavelength fluorescence analysis (FF) method measures the excitation:emission 
wavelength pairs 290:334 nm (2/3 ring-type), 341:383 nm (pyrene-type) and 380:430 nm 
(benzo[a]pyrene-type). 
The GC-MS bile metabolites analysis showed suprising results (Figure 14). Highest levels of 
methylnaphthols, hydroxyfluorenes and hydroxyphenanthrenes were observed in the PW group, 
while levels of 1-hydroxypyrene were highest in the oil- and PAH treated groups. In the PW exposure 
dose, 94 % were 2 rings PAHs and the methylnaphthalene contributed 16 % of the total PAH, where 
phenanthrene only contributed 1.6 % of the total PAHs. Nevertheless, in the bile the 3 ring PAH 
metabolites dominated, and levels of hydroxyphenanthrene were from 24-905 ng/ml, while levels of 
hydroxylated methylnaphthols were only slightly elevated (11-42 ng/ml) compared with control.  
Similarly, in the oil exposed groups we expected to find high levels of hydroxyphenanthrenes, but the 
levels were not significantly different from control group. The 1-hydroxypyrene, on the other hand, 
was strongly elevated in the oil and PAH exposed groups, so this metabolite seems to be a good 
marker for exposure. 
One explanation for the results with GC-MS may be that the monohydroxylated (phenols types) 
metabolites are not the dominating metabolites, and more of the metabolites are dihydroxylated or 
even more polar (Goksoyr et al. 1986;Pangrekar et al. 2003;Sette et al. 2013;Wessel et al. 2013). 
Goksøyr et al., (1986) found, for example, that more than 90 % of the bile metabolites of 
phenanthrene in cod were dihydrodiols. The same may be the case for the alkylated PAHs, as 
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benzylic hydroxylation may be the dominating metabolic pathway and phenolic metabolites only will 
be present in small amount (Malmquist et al. 2015).  
The FF method gave a different picture than GC-MS. This method measures fluorescence at different 
wavelengths and is not restricted to a single compounds, but more the structure of the aromatic 
rings. This measurement will therefore be able to detect several different metabolites, both mono- 
and polyhydroxylated and more polar compounds (Aas et al. 2000b).  
Figure 15 shows bile metabolites analysed by the FF method sampled after one month (23.03) and 
two month (22.04) exposure and after one week of recovery (29.04). Significantly higher levels of the 
2/3 ring metabolites (290/334 nm) were observed in the PW group after one and two months of 
exposure, but not after one week of recovery. The PW exposed group  also had slightly elevated 
levels of 4 rings metabolites (341/383 nm) after one month of exposure, but this was not seen after 
two months of exposure. The oil exposed fish showed very high levels of 2/3 ring-type metabolites 
for all exposure lenghts. The 4 ring metabolites were also elevated at all exposure durations. The PAH 
group had elevated levels of 4 ring metabolites after both one and two month of exposure (no bile 
data were optained for the PAH fish after one week of recovery). Surprisingly, the PAH group did not 
show elevated amounts of the 5 rings PAH metabolites (380/430 nm = benzo[a]pyrene-type) even 
though these compounds were dominating the exposure regime in this treatment. Unfortunately, we 
did not obtain FF measurement for BaP in the injected fish that could confirm the FF method ability 
to detect BaP metabolites in haddock bile, but the FF methods have been validated for BaP in many 
others fish, including Atlantic cod (Aas et al. 2000b).   
We compared the GC-MS and FF methods and Figure 16 shows that there was a linear correlation 
between the FF method and the GC-MS measurement for naphthtols (y=0.0078x + 4.51, R² = 0.36), 
the methylnaphthols (y=0.044x + 6.32, R² = 0.67) but not hydroxylated phenanthrene (y=0.22x + 110, 
R² = 0.03) for the PW group. In the oil group there was correlation between the FF and the GC-MS for 
the hydroxyphenanthrene (y = 0.11x - 78.16, R² = 0.71). The correlation between the 4 rings 
metabolites (P341/383 nm = pyrene type) and GC-MS measurement of 1-hydroxypyrene was very 
high for both the oil group (y=1.18x - 122, R² = 0.96) and the PAH group (y=1.66x – 192, R² = 0.48) 
(figure 16). 
The good correlation found between the two different methods confirms that the low detection of 
monyhydroxylated PAH in the GC-MS measurement is most likely accurate, and not a result of 
method problems. The GC-MS method performance is repeatedly controlled by running standard 
samples for hydroxylated PAHs. This method control validates the preformance of the extraction, 
derivatisation and GC-MS step, however, it is not possible to have standard control for the enzymatic 
deconjugation process (beta-glucuronidase/aryl sulfatase, first step of the method), because it is not 
possible to obtain standards of the main bile conjugate gluconoids of PAH metabolites (or it is 
extremly expensive). IMR has participated in an intercalibration excersise for the GC-MS method and 
the results were validated as good (Kammann et al. 2013). 
The relative low detection rate of PAH metabolites in the GC-MS analysis raises the question whether 
this is the right method to use for bile analysis in the water coloum monitoring, because this method 
does not target the most abundant metabolites. The FF method, on the other hand, can only be 
regarded as semi-quantitative as there are no standards that can cover for the complex mixture of 
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metabolites that can be found in bile samples (Beyer et al. 2010). Likewise, the wavelengths chosen 
for excitation and emission represent a compromise that does not cover the optimum for all 
metabolites of the group (Pampanin et al. 2016). 
Several methods have been developed using LC-MS enabling analyse of intact conjugated 
metabolites and deconjugated products (Huang et al. 2014;Malmquist et al. 2015;Sette et al. 2013). 
We aim to re-examine samples form the present experiment using LC-MS/MS at the laboratorie of 
NOAA, Seattle. This will give us a better understanding of the metabolism of orally distributed PAHs 
in haddock.  
 
Figure 14. GC-MS analysis of monohydroxylated PAH bile metabolistes in fish from the different treatments 
groups after two-months of oral exposure (n=10). Data presented as average ± stdev. (* or **) indicate 
significant differences compared with control, p< 0.05 or p< 0.01. 
 
Figure 15. Fixed wavelength fluorescence (FF) analysis of PAH bile metabolites. FF were measured at the 
290/334 nm (2/3 ring-type), P341/383 nm (pyrene-type) and 380/430 nm (benzo[a]pyrene-type). Levels are 
shown after 1 month exposure (23.03), two months exposure (22.04) and after one week recovery with non 
contaminated food (29.04). Data presented as average ± stdev. (**) indicate significant differences compared 
with control, p< 0.01. 
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Figure 16. Comparison between the GC-MS measurements and the FF measurements for haddock after 
exposure for 2 months (sampled 22.04). FF 290/335 nm (2-3 rings PAH) plotted against amount of naphthols, 
methylnaphthols and hydroxyphenanthrene.  
 
Figure 17. Comparison between the GC-MS measurement and the FF measurement for the haddock exposed 
for 2 months (sampled 22.04). FF 341/383 nm (pyrene) plotted against the amount of 1-hydroxypyrene.  
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Figure 18. FF analyses of PAH bile metabolites from haddock injected with single PAH compounds or only 
DMSO (control). Three samples (PY, BAA, BEB) had extrem high levels of fluorescence in the bile – while most 
samples not were higher that the control. Unfortunately, many of the fish contained very little bile and FF 
analyses could not be preformed on these samples. 
 
3.5 Liver analysis of PAH content 
Because of the surprisingly low levels of bile metabolites from the GC-MS measurement, we decided 
to analyze levels of non-metabolized PAH in the liver to see if PAH were accumulating in the fat rich 
tissue. The analyses were done by DCM extraction followed by GPC cleanup and GC-MS/MS analysis 
(Sørensen et al. 2016). 
The results showed large amounts of PAHs in the liver of the PW treatment groups. The profile of 
PAHs in the livers of PW exposed fish were dominated by 2 rings, followed by 3 rings PAHS, which 
reflected the profile in the feed. PAHs were also found in the oil group, however, in much lower 
amount. No heavy PAHs were detected in the PAH treatment group. 
As a comparison, we made a theoretical calculation of how much the total liver content of PAH 
(concentration (ng/g) x liver size (g)) was related to a single dose with food (1 % of body weight).  
In the PW group the naphthalene content in the liver corresponded 34 % of the naphthalene in one 
dose, for the alkylated two-ring PAHs it corresponded to 16 %, for the 3 ring PAHs it was 51 % and for 
the alkylated three-ring PAHs it was 12 %. The similar calculation for the oil group showed that a 
much lower part of the total PAH dose was found in the liver; 3 ring PAHs were 2.4%, alkylated three-
ring PAHs were 0.1 % and for the 4 ring PAHs it was 0.5 %. For both the PW and the oil group it is 
clear that much lower amount of the alkylated PAHs were found compared with the non alkylated 
PAHs, suggesting a faster clearing rate for alkylated PAHs. 
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This is a very interesting result, suggesting that the PW exposed fish most likely accumulated PAHs in 
the liver because the detoxification systems were not induced as strongly as the oil and PAH groups. 
This fits well with what should be expected, because the small 2 ring PAHs are not agonists for the 
AhR, which is responsible for the induction of the metabolic enzymes (cytochrome P450, CYP) for 
PAHs. Many heavy PAHs, (4-6 rings) are very strong CYP inducers, likewise alkylated 3 rings PAH have 
been shown to bind to AhR and induce the CYP systems (Billiard et al. 2002). It is commonly found 
that oil exposure in fish results in a strong induction of CYP1A, and that this increases the metabolism 
of PAHs. Fish have high capacity for metabolizing PAHs and normally non-metabolized PAHs are 
found only in very low levels in tissues like liver and muscle (Hellou et al, 1994). CYP1A was induced 
in the liver of oil and the PAH treated fish (Figure 19 and 24), but not in liver of the PW treated fish. 
This difference in induction of the detoxicification system in the oil group may also explain the 
picture higher levels of bile metabolites (2/3 rings-type) found in this exposure group compared with 
the PW group. 
0
200
400
600
800
1000
1200
SUM 2-ring SUM alk 2-ring
PA
H
 in
 L
iv
er
 (n
g
/g
)
Control
PW
Oil
Heavy PAH
0
10
20
30
40
50
60
70
SUM 3-ring SUM alk 3-ring SUM 4-ring SUM alk 4-ring SUM 5-6 ring
PA
H
 in
 li
ve
r 
(n
g
/g
)
Control
PW
Oil
Heavy PAH
**
**
**
**
**
**
** ****
 
Figure 19. PAH found in the liver (ng/g) of the different treatments groups. Data presented as average ± stdev. 
(*) indicate significant differences compared with control, p< 0.05. 
 
3.6 Effects on selected biomarkers 
Exposure of fish to different PAH profiles may work through different mechanisms and lead to 
different cellular responses or different strength in responses. We have selected a few different 
biological effect parameters relevant for exposures to different PAHs measured at the cellular level 
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by mRNA levels (qPCR), protein levels (ELISA), enzymatic levels (GST activity) and membranes lipid 
peroxidation. 
CYP1A is known to be induced by planar PAHs and dioxins, furans and planar PCBs (Goksøyr and 
Förlin 1992). Figure 20 shows qPCR analyses of CYP1A and aryl hydrocarbon receptor repressor 
(AHRR). The mean normalized expression (MNE) for CYP1A is strongest after exposure to the PAH 
exposure group (4-, 5-, and 6-ringed PAHs), with medium response in the oil-type exposure group (3- 
and 4-ringed PAHs), and less in the PW-type exposure group (2- and 3-ringed PAHs). The same 
pattern was observed with qPCR with primers to AHHR (Figure 20b). AHRR participates in the AhR 
signaling cascade, which mediates induction of the detoxification system. It functions as a feedback 
modulator by repressing AhR-dependent gene expression. It represses the transcription activity of 
AHR by competing with this transcription factor for heterodimer formation with the ARNT and 
subsequently binding to the xenobiotic response element (XRE) sequence present in the promoter 
regulatory region of variety of genes. It represses CYP1A1 by binding the XRE sequence and recruiting 
ANKRA2, HDAC4 and/or HDAC5. AHRR also autoregulates its expression by associating with its own 
XRE site (uniprot.org). To investigate responses in the cellular DNA repair system, we also included 
primers to transcripts involved in DNA repair processes like growth arrest and DNA damage inducible 
proteins (GADD) involved in the P53 signaling pathway as GADD45A, GADD45G and p53 (results not 
shown). However, we did not obtain a significant difference in response compared with control to 
these transcripts, even if we did see a clear response in DNA adduct formation in this study. 
ELISA analyses of CYP1A in liver were included to provide information on expression at protein levels. 
Such information is important complementary information to RNA-Seq. For CYP1A we could see the 
same pattern on the protein levels as we could see in the qPCR analyses, although the relative 
differences from control to exposed groups were higher in the qPCR analyses (Figure 20A).  
Measurements on glutathione-S-transferase activity (GST) were included to investigate if these 
different exposures affected the phase-2 detoxification proteins like GST. GST levels in the exposed 
groups were not significantly different from control, even if levels in the heavy PAH groups seemed 
to have reduced levels (Fig 25B).  
Oxidative stress is also a relevant biomarker to include after exposure to PAHs. Measurements of 
lipid peroxidation did not reveal significant changes in the exposed groups compared with control 
(Fig 25C).  
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Figure 20. Mean normalized expression (MNE) of CYP1A (A) and AHRR (B) by qPCR after 2 months of exposure. 
Data presented as average ± stdev. (*) indicate significant differences compared with control, p< 0.05. 
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Figure 21. Responses on CYP1A by ELISA with antibody towards CYP1A (A), effects on glutathions-S-transferase 
activity (GST) (B) and lipid peroxidation (LPO) (C) of the different treatments groups after two months of 
exposure. Data presented as average ± stdev. For CYP1A detection we used polyclonal anti-trout CYP1A (CP-
226, Biosense) diluted 1:1000. (*) indicate significant differences compared with control, p< 0.05. N = 10 
individuals per group. 
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3.7 RNA-Seq 
RNAseq analyses have been performed on liver from 4 individual haddock per treatment sampled 
after 2 months (22nd April, 2014) of oral exposure to feed spiked with different PAH profiles 
(resembling oil, produced water and pyrogenic PAHs) followed by two months of recovery with 
normal feed, sampled 19th June 2014. A total of 32 individuals were analysed. RNAseq analyses can 
show which metabolic or other cellular pathways that may be affected when comparing the different 
treatments. 
A total number of 20096 transcripts were sequenced and annotated to known genes. When 
comparing differential expression pattern between groups, 985 RNA transcripts were significantly 
differentially expressed with fold changes >1.5 and Noiseq > 0.95.  
The general conclusion we must draw from this analysis is that the low number of individual (n=4) is 
not sufficient to obtain significant differences between the treatment groups. Due to high cost and 
delivery time for the analyses we only analysed four individual samples per treatment. Such low 
number per group restricts normal distribution and statistical significance. Only a relative low 
number of genes were found to be differentially expressed between the different exposure and the 
control group; 30 genes were upregulated and 123 down regulated (Table 8). 
Table 8. Differentially expressed genes by treatment sampled after two months of exposure (22nd April) and 
after two months of recovery (19th June). Fold changes > 1.5, p< 0.05 (Noiseq > 0.95).  
Treatment Upregulated Downregulated 
Control vs PW 1 0 
Control vs Oil 26 2 
Control vs PAH 0 12 
Recovery control vs recovery PW 0 41 
Recovery control vs recovery oil 0 34 
Recovery control vs recovery PAH 0 41 
 
The most robust responses in this data set were CYP1A (Figure 22). This biomarker gave significant 
changes between control and oil exposure sampled 22nd April when Noiseq was set at 1.0. When 
expression between all individuals were compared, CYP1A showed similar expression pattern as we 
observed with qPCR (Figure 20) and ELISA (Figure 21). For Ah-receptor (AHR), oil exposure gave the 
highest response, while transcription levels of Ah receptor repressor (AHRR) gave the same pattern 
for RNAseq as observed by qPCR (Figure 20). After two months of recovery, expression levels were 
similar as control levels for these transcripts (not shown). 
The objective to perform RNAseq analyses is to investigate metabolic pathways affected by the 
different exposures and search for new biomarker candidates for such exposures. We did especially 
focus on pathways know to be involved with genotoxic stress, like the p53 signalling pathway (a 
protection system that either drive damages cells to cell-cycle arrest or apoptosis) and the DNA 
repair system. These genes are all included in pathways in cancer (Pathway ID 5200) and when we 
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compared control versus oil treatment transcripts, we found 13 effected gene products (Figure 23).  
None of the effected genes were directly involved in the p53 and gene repair system  
We have identified several pathways with differential gene expression from KEGG analyses, like the 
Pancreatic secretion (Pathway ID 4972) and the Protein digestion and absorption (Pathway ID 4974), 
where 14 and 11 gene products were effected when comparing control versus oil exposed.  
However, the low number of samples included in this RNA-Seq study make it difficult to make clear 
conclusion from this results.  
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Figure 22. Transcript levels of (A) CYP1A1, (B) Ah-receptor (AHR) and (C) Ah receptor repressor (AHRR) in 
haddock sampled 22nd April (after two months of exposure). N=4 per group. Statistical significant differences 
were not obtained due to small samples size. 
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Figure 23. Effected transcripts in KEGG pathways in cancer for treatments control vs oil 2204. Green colour 
indicates upregulation in oil treatment, red colour indicates downregulation. Settings: 0,95 % confidence 
interval; fold change threshold: 1.5. 
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3.8 Lipid analysis. 
Field studies on haddock (Balk et al. 2011;Grøsvik et al. 2012) reported differences in the fatty acid 
(FA) composition between haddock from Tampen and Egersund Bank that indicate a reduction of (n-
3) FA and increase of (n-6) FA in haddock from Tampen. 
We have investigated whether PAH exposure can affect lipid metabolism/biosynthesis in haddock 
and thereby change the FA composition in a similar way as observed in field samples. These analyses 
also provide information on energy status of the fish, which is important for the evaluation of the 
long-term effects on fitness. The lipid content and FA composition were analyzed from the haddock 
liver (storages lipid), haddock muscle (membrane lipids) and the feed.   
3.8.1 Comparison of FA profiles in the diet and the fish. 
The haddock liver is very lipid rich (48-61% relative to wet weight) and is totally dominated by 
triacylglycerols (TAG) (>95 %), which is a lipid for energy storage. The muscle is very lean (0.8-1%) and 
contains only phospholipids (PL) and cholesterol (membrane lipids). Figure 24 shows the FA profile in 
the diet and in haddock liver and muscle (control fish from 22/4 are used as example). The FA profile 
of the muscle shows a typical PL FA profile with very high levels of polyunsaturated (PUFA) of 52 % of 
the total FAs, saturated FAs (SFA) contribute with 24 % and monounsaturated FAs (MUFA) also with 
24 %. The PUFA is dominated by (n-3) FAs (46 %), and 22:6 (n-3) and 20:5 (n-3) contribute with 27 % 
and 14 % of the total FAs. The (n-6) PUFA contribute with 6 % of the total FAs and the (n-3)/(n-6) 
ratio is 8. The FA profile in the liver is dominated of MUFA (47 %) followed by PUFA (27 %) and SFA 
(26 %), the (n-3)/(n-6) ratio in the liver is 4. The fish were given a marine diet (13 % lipid) made on 
fish meal and fish oil (herring). The FA profile in the food is like the FAs profile in the liver, MUFA (47 
%), PUFA (28 %) and SFA (25 %), and the (n-3)/(n-6) ratio is 4 similar as for the liver (Table A10). 
However, even though the FA profiles have many similarities, there were also some clear differences 
between the diet and the liver.  Figure 25 shows a PCA plot of the feed and haddock liver and muscle 
from control fish from all five samples times. The PCA models explain 89 % of the total variances; 
Along PC1 is the muscle samples separated from the liver and diet samples. The food and the liver 
show little separation along PC1, but they are strongly separated along PC2. Both from the loading 
plot (figure 25) and Figure 24, the diet has relatively higher levels of long chain MUFAs, 22:1 (n-11), 
22:1 (n-9) and 20:1 (n-9) and the short SFA, 14:0, while the haddock livers are high in short chain 
MUFAs 18:1 (n-9), 18:1 (n-7) and 16:1 (n-7) and middle chain length SFA (16:0 and 18:0).  
This shows that the haddock modify the fatty acids from the diet both by elongation (14:0 to 16:0 
and 18:0) and Δ9-desaturation (18:0 to 18:1 (n-9)). In addition, the FA profile of the liver suggests a 
strong selective metabolism towards high use of the long chain MUFA for catabolic energy.  
In the food 22:1 (n-11) contributes to 16 % of the total FAs and 20:1 (n-9) to 10 %, while these two FA 
only contribute to 6 % and 7 % of the total FAs in the liver. On the other hand, the liver has 19 % of 
18:1 (n-9) and the food only 8 %. This results shows that haddock have a very active metabolic 
modification of the diet FAs and especially selective catabolism of long chain MUFA, which is 
commonly seen in marine fish (Stubhaug et al. 2007).         
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Figure 24. Fatty acid profile of the feed, haddock liver and muscle (control fish form 22/4). Only the 31 
dominating FA are included in the figure (26 minor FAs that contributed less that 0.3 % has been removed). 
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Figure 25. Principal component analysis of FA profiles from feed, haddock liver and muscle (control fish). A) 
shows the score plot and B) show the loading plot. The model explain 89 % of the total variance (PC1=78% and 
PC2=11%). Only FA that contributes to more than average to the PCA model are included in the loading plot.   
 
3.8.2 Differences in lipid amount found in liver and muscle between the treatment groups 
There were no differences in the total amount of lipids in the liver between the treatments (Figure 
26). Muscle samples contained higher levels of lipids in the PW group, but lower levels of lipid in the 
oil and PAH treated groups compared with control after one month of exposure (24/3) (table 9). 
However, no differences in lipid content in the muscles were observed after two-months of exposure 
(22/4) and after one month of recovery (29/4) (table A8-A10). 
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Figure 26. Lipid content in the liver of the different treatments during exposure (A and B) and recovery (C and 
D). Data presented as average ± stdev. 
 
3.8.3 Differences in FA profile in the liver of different treatments groups 
Small but significant differences between the FA composition in the liver of the control fish and the 
livers of the oil and PAH exposed fish were measured. Figure 27 shows score and loading plot of PCA 
for FA composition in haddock livers after one (A/B) and two-month (C/D) exposure. The FA profiles 
are presented in table 10 (24/3), table A4 (22/4), table A5 (29/4) and table A6 (19/6).  
After one month of exposure the PAH group separates from the control group along PC1, while the 
PW group overlaps with the control and the oil group overlaps with both the control and the PW 
group (Figure 25A). After two months of exposure the oil and PAH exposed fish overlapped more in 
the PCA and separated from the PW and control group. There are many differences in FA between 
control and the PAH group, but the general picture is that the long chain MUFA (22:1 and 24:1) are 
relatively lower in the PAH exposed group and the middle chain length MUFA, 18:1 (n-9) and 18:1(n-
7) are higher compared with control. Lower levels of the long chain PUFA, 22:6 (n-3) in the livers of 
the PAH and oil treated fish were also measured. This resulted in slight reduction in the (n-3)/(n-6) 
ratio after two-month exposure (only significant in the oil group). No differences in the (n-6) PUFAs 
levels were measured. This difference between the treatment groups was also seen after one week 
recovery, but not after 2 months of recovery.  
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Figure 27. Principal component analysis of FA profiles in the liver from the different treatment 
groups after one month exposure (24/3) (A=Score plot and B=Loading plot). The model explains 49 % 
of the total variance (PC1=32% and PC2=17%). Score plot (C) and loading plot (D) of FA profiles in the 
liver after two-month exposure. The model explains 45 % of the total variance (PC1=24% and 
PC2=21%). Only the FA that contributes more than average to the PCA model are included in the 
loading plot.  
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Table 9. Fatty acid profile in haddock liver from the different treatments groups after one month of exposure. 
FA that represents less than 0.1 % of the total FAs are removed from the table, but is included in the total sum 
of FAs. The total amount of FAs relative to wet weight is given. Data presented as average ± stdev. Bold 
numbers indicate significant differences compared with control, p< 0.05. 
24/3 24/3 24/3 24/3
Control (24/3) PW (24/3) Oil (24/3) PAH (24/3)
(n=10) (n=10) (n=10) (n=10)
 14:0 3.50 ± 0.29 3.52 ± 0.17 3.53 ± 0.20 3.43 ± 0.26
Iso 15:0 0.14 ± 0.01 0.14 ± 0.01 0.14 ± 0.01 0.13 ± 0.01
 15:0 0.32 ± 0.02 0.32 ± 0.02 0.31 ± 0.02 0.31 ± 0.02
 16:0 17.41 ± 0.77 17.22 ± 1.08 17.78 ± 1.34 17.27 ± 1.33
Iso 17:0 0.27 ± 0.01 0.27 ± 0.01 0.28 ± 0.05 0.27 ± 0.01
Antiso 17:0 0.10 ± 0.01 0.10 ± 0.00 0.10 ± 0.01 0.10 ± 0.01
 17:0 0.22 ± 0.02 0.23 ± 0.02 0.23 ± 0.03 0.23 ± 0.02
 18:0 3.83 ± 0.66 4.21 ± 0.68 4.21 ± 0.60 4.14 ± 0.40
 20:0 0.15 ± 0.01 0.15 ± 0.01 0.14 ± 0.01 0.12 ± 0.01
∑SFA 26.34 ± 0.89 26.59 ± 1.20 27.13 ± 1.41 26.29 ± 1.43
16:1 (n-11) 0.18 ± 0.02 0.18 ± 0.02 0.17 ± 0.03 0.19 ± 0.04
16:1 (n-9) 0.34 ± 0.03 0.33 ± 0.02 0.32 ± 0.02 0.33 ± 0.03
16:1 (n-7) 5.47 ± 0.29 5.29 ± 0.38 5.35 ± 0.39 5.44 ± 0.34
16:1 (n-5) 0.16 ± 0.02 0.15 ± 0.01 0.15 ± 0.01 0.15 ± 0.01
∑17:1 0.51 ± 0.02 0.50 ± 0.02 0.48 ± 0.03 0.47 ± 0.04
18:1 (n-11) 0.87 ± 0.14 0.89 ± 0.17 0.77 ± 0.20 0.54 ± 0.10
18:1 (n-9) 19.61 ± 1.34 19.44 ± 0.91 19.51 ± 1.12 20.88 ± 1.29
18:1 (n-7) 3.53 ± 0.22 3.54 ± 0.14 3.55 ± 0.17 3.85 ± 0.20
18:1 (n-5) 0.32 ± 0.01 0.32 ± 0.01 0.32 ± 0.02 0.34 ± 0.02
20:1 (n-11) 1.15 ± 0.11 1.16 ± 0.07 1.04 ± 0.11 0.95 ± 0.07
20:1 (n-9) 4.75 ± 1.77 5.02 ± 1.44 5.16 ± 0.89 5.21 ± 0.41
20:1 (n-7) 0.21 ± 0.01 0.22 ± 0.01 0.21 ± 0.01 0.20 ± 0.01
22:1 (n-11) 6.92 ± 0.67 6.73 ± 0.50 6.41 ± 0.56 5.60 ± 0.45
22:1 (n-9) 0.56 ± 0.03 0.55 ± 0.03 0.54 ± 0.03 0.48 ± 0.03
22:1 (n-7) 0.09 ± 0.01 0.09 ± 0.01 0.08 ± 0.01 0.05 ± 0.01
24:1 (n-9) 0.67 ± 0.05 0.67 ± 0.04 0.65 ± 0.06 0.57 ± 0.04
24:1 (n-7) 0.11 ± 0.02 0.10 ± 0.01 0.09 ± 0.03 0.08 ± 0.03
∑MUFA 45.46 ± 1.42 45.21 ± 0.96 44.85 ± 0.91 45.37 ± 0.82
16:4 (n-1) 0.38 ± 0.05 0.39 ± 0.03 0.40 ± 0.05 0.41 ± 0.03
18:4 (n-1) 0.13 ± 0.01 0.14 ± 0.01 0.14 ± 0.02 0.16 ± 0.01
16:2 (n-4) 0.34 ± 0.04 0.35 ± 0.02 0.34 ± 0.02 0.36 ± 0.02
16:3 (n-4) 0.31 ± 0.04 0.32 ± 0.02 0.32 ± 0.03 0.35 ± 0.03
18:2 (n-4) 0.24 ± 0.03 0.24 ± 0.02 0.24 ± 0.03 0.26 ± 0.02
18:2 (n-6) 4.04 ± 0.22 4.05 ± 0.22 4.02 ± 0.24 4.08 ± 0.23
18:3 (n-6) 0.14 ± 0.02 0.13 ± 0.03 0.13 ± 0.03 0.13 ± 0.03
20:2 (n-6) 0.31 ± 0.02 0.32 ± 0.01 0.31 ± 0.02 0.31 ± 0.01
20:3 (n-6) 0.07 ± 0.00 0.07 ± 0.00 0.07 ± 0.00 0.08 ± 0.01
20:4 (n-6) 0.49 ± 0.03 0.48 ± 0.02 0.47 ± 0.02 0.47 ± 0.04
22:4 (n-6) 0.13 ± 0.01 0.12 ± 0.01 0.13 ± 0.02 0.14 ± 0.02
22:5 (n-6) 0.16 ± 0.02 0.16 ± 0.01 0.16 ± 0.01 0.15 ± 0.01
18:3 (n-3) 1.05 ± 0.08 1.06 ± 0.07 1.07 ± 0.08 1.11 ± 0.07
18:4 (n-3) 1.73 ± 0.15 1.74 ± 0.10 1.75 ± 0.14 1.82 ± 0.12
20:3  (n-3) 0.12 ± 0.01 0.12 ± 0.01 0.11 ± 0.01 0.12 ± 0.01
20:4 (n-3) 0.56 ± 0.03 0.56 ± 0.02 0.54 ± 0.03 0.53 ± 0.02
20:5 (n-3) 7.05 ± 0.48 7.06 ± 0.30 7.02 ± 0.36 7.30 ± 0.32
21:5 (n-3) 0.32 ± 0.03 0.33 ± 0.02 0.32 ± 0.03 0.33 ± 0.03
22:5 (n-3) 1.20 ± 0.19 1.31 ± 0.07 1.25 ± 0.19 1.30 ± 0.17
22:6 (n-3) 8.95 ± 0.38 8.77 ± 0.16 8.76 ± 0.40 8.43 ± 0.59
24:5 (n-3) 0.23 ± 0.02 0.23 ± 0.02 0.23 ± 0.02 0.23 ± 0.03
∑PUFA 28.19 ± 1.49 28.20 ± 0.95 28.02 ± 1.49 28.34 ± 1.44
∑(n-6) PUFA 5.37 ± 0.26 5.38 ± 0.23 5.33 ± 0.29 5.40 ± 0.26
∑(n-3) PUFA 21.27 ± 1.13 21.24 ± 0.66 21.10 ± 1.10 21.22 ± 1.16
(n-3)/(n-6) 3.97 ± 0.13 3.95 ± 0.06 3.96 ± 0.07 3.93 ± 0.15
Amount of Cholesterol (%) 0.22 ± 0.03 0.24 ± 0.03 0.23 ± 0.03 0.19 ± 0.02
Amount of FA (%) 54.52 ± 3.84 51.04 ± 5.99 54.30 ± 2.94 53.84 ± 4.45  
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3.8.4 Differences in FA profile in the muscle of different treatment groups 
The FA profile in the muscle of the PAH treated fish shows several differences from the control, 
although, in an inconsistent manner between the different sampling times. After one month of 
exposure, higher levels of SFA and MUFA and less PUFA were found in the exposed fish (Table 10), 
but after two month and also after one week of recovery (Table A7 and A8), PAH treated fish had on 
the contrary higher levels of PUFA (mainly 20:5 (n-3)). After 2 months of recovery lower levels of the 
two long chain MUFAs (22:1 (n-11) and 24:1 (n-9)) were observed. No significant differences in the 
(n-3)/(n-6) between the treatment groups were measured at any of the sampling times. The PCA 
analyses (Figure 28) did not find separation along the PC1 between the different treatments groups, 
which shows that for the whole FA profile larger variations are found inside the groups than between 
the different treatments groups. 
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Figure 28. PCA of FA profiles in the muscle from the different treatment groups after one month of exposure 
(24/3) (E=Score plot and F=Loading plot). The model explains 57 % of the total variance (PC1=37% and 
PC2=21%). Score plot (G) and loading plot (H) of FA profiles in the muscle after two-month exposure (22/4). 
The model explains 68 % of the total variance (PC1=51% and PC2=17%).  
 
 
 40 
 
 
Table 10. Fatty acid profile in haddock muscle from the different treatments groups after one month of 
exposure. FA that represents less than 0.1 % of the total FAs are removed from the table, but is included in the 
total sum of FAs.   Data presented as average ± stdev. Bold numbers indicate significant differences compared 
with control, p< 0.05. 
Muscle Control (24/3) PW (24/3) Oil (24/3) PAH (24/3)
(n=10) (n=10) (n=9) (n=10)
 14:0 2.50 ± 0.42 2.44 ± 0.35 2.29 ± 0.28 2.11 ± 0.29
Iso 15:0 0.09 ± 0.02 0.09 ± 0.01 0.08 ± 0.02 0.07 ± 0.01
 15:0 0.35 ± 0.03 0.35 ± 0.02 0.33 ± 0.03 0.32 ± 0.03
 16:0 17.44 ± 0.72 17.54 ± 0.86 17.81 ± 0.67 18.32 ± 0.87
Iso 17:0 0.19 ± 0.02 0.19 ± 0.01 0.23 ± 0.05 0.20 ± 0.01
Antiso 17:0 0.06 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.07 ± 0.01
 17:0 0.19 ± 0.00 0.19 ± 0.01 0.22 ± 0.02 0.22 ± 0.02
 18:0 2.79 ± 0.25 2.74 ± 0.18 3.40 ± 0.41 3.48 ± 0.25
 20:0 0.03 ± 0.00 0.03 ± 0.01 0.04 ± 0.01 0.04 ± 0.01
∑SFA 24.01 ± 0.62 24.03 ± 0.75 24.82 ± 0.63 25.14 ± 0.85
16:1 (n-11) 0.16 ± 0.03 0.15 ± 0.02 0.17 ± 0.05 0.14 ± 0.02
16:1 (n-9) 0.33 ± 0.05 0.33 ± 0.06 0.34 ± 0.06 0.32 ± 0.04
16:1 (n-7) 2.36 ± 0.42 2.37 ± 0.40 2.27 ± 0.31 2.08 ± 0.31
16:1 (n-5) 0.26 ± 0.02 0.24 ± 0.02 0.22 ± 0.02 0.22 ± 0.02
∑17:1 0.36 ± 0.04 0.36 ± 0.04 0.28 ± 0.07 0.32 ± 0.05
18:1 (n-11) 0.99 ± 0.20 0.94 ± 0.16 1.30 ± 0.25 1.10 ± 0.25
18:1 (n-9) 8.70 ± 0.91 8.84 ± 1.05 9.20 ± 0.85 9.23 ± 0.94
18:1 (n-7) 2.24 ± 0.10 2.28 ± 0.13 2.44 ± 0.14 2.49 ± 0.11
18:1 (n-5) 0.26 ± 0.02 0.26 ± 0.02 0.27 ± 0.02 0.25 ± 0.01
20:1 (n-11) 0.43 ± 0.05 0.44 ± 0.05 0.46 ± 0.08 0.43 ± 0.09
20:1 (n-9) 2.12 ± 0.27 2.06 ± 0.29 2.38 ± 0.37 2.32 ± 0.35
20:1 (n-7) 0.06 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.05 ± 0.01
22:1 (n-11) 1.27 ± 0.29 1.28 ± 0.40 1.39 ± 0.32 1.28 ± 0.32
22:1 (n-9) 0.16 ± 0.03 0.16 ± 0.04 0.17 ± 0.03 0.16 ± 0.03
22:1 (n-7) 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.01 0.04 ± 0.02
24:1 (n-9) 0.81 ± 0.06 0.78 ± 0.16 0.90 ± 0.10 0.91 ± 0.12
24:1 (n-7) 0.18 ± 0.04 0.19 ± 0.05 0.11 ± 0.02 0.12 ± 0.01
∑MUFA 20.77 ± 2.02 20.83 ± 2.25 22.01 ± 2.11 21.46 ± 1.88
16:4 (n-1) 0.06 ± 0.03 0.07 ± 0.03 0.05 ± 0.02 0.04 ± 0.01
18:4 (n-1) 0.10 ± 0.01 0.10 ± 0.02 0.09 ± 0.02 0.07 ± 0.01
16:2 (n-4) 0.16 ± 0.03 0.16 ± 0.03 0.15 ± 0.02 0.13 ± 0.03
16:3 (n-4) 0.06 ± 0.02 0.07 ± 0.02 0.05 ± 0.02 0.05 ± 0.01
18:2 (n-4) 0.13 ± 0.01 0.14 ± 0.01 0.14 ± 0.01 0.13 ± 0.01
18:2 (n-6) 3.68 ± 0.16 3.68 ± 0.15 3.65 ± 0.16 3.62 ± 0.17
18:3 (n-6) 0.06 ± 0.01 0.08 ± 0.02 0.07 ± 0.01 0.09 ± 0.07
20:2 (n-6) 0.33 ± 0.04 0.34 ± 0.05 0.37 ± 0.03 0.36 ± 0.04
20:3 (n-6) 0.100 ± 0.004 0.104 ± 0.007 0.106 ± 0.005 0.109 ± 0.005
20:4 (n-6) 1.22 ± 0.08 1.25 ± 0.10 1.23 ± 0.10 1.23 ± 0.09
22:4 (n-6) 0.14 ± 0.02 0.14 ± 0.01 0.16 ± 0.01 0.16 ± 0.01
22:5 (n-6) 0.47 ± 0.03 0.47 ± 0.03 0.47 ± 0.03 0.48 ± 0.03
18:3 (n-3) 0.76 ± 0.06 0.77 ± 0.07 0.73 ± 0.06 0.69 ± 0.07
18:4 (n-3) 1.11 ± 0.13 1.11 ± 0.12 1.00 ± 0.10 0.92 ± 0.12
20:3  (n-3) 0.11 ± 0.01 0.11 ± 0.01 0.11 ± 0.01 0.09 ± 0.01
20:4 (n-3) 0.69 ± 0.03 0.70 ± 0.06 0.66 ± 0.04 0.62 ± 0.04
20:5 (n-3) 15.52 ± 0.75 15.46 ± 0.68 14.72 ± 0.87 14.49 ± 0.37
21:5 (n-3) 0.30 ± 0.01 0.30 ± 0.02 0.29 ± 0.01 0.29 ± 0.02
22:5 (n-3) 1.77 ± 0.04 1.75 ± 0.05 1.71 ± 0.05 1.70 ± 0.04
22:6 (n-3) 27.98 ± 1.47 27.87 ± 1.67 27.00 ± 1.44 27.72 ± 1.25
24:5 (n-3) 0.29 ± 0.02 0.28 ± 0.03 0.28 ± 0.04 0.27 ± 0.10
∑PUFA 55.22 ± 1.92 55.13 ± 1.94 53.17 ± 2.09 53.40 ± 1.19
∑(n-6) PUFA 6.06 ± 0.15 6.11 ± 0.17 6.07 ± 0.15 6.05 ± 0.21
∑(n-3) PUFA 48.61 ± 2.02 48.45 ± 2.07 46.56 ± 2.10 46.86 ± 1.28
(n-3)/(n-6) 8.02 ± 0.42 7.94 ± 0.45 7.67 ± 0.33 7.75 ± 0.37
Amount of Cholesterol (%) 0.06 ± 0.01 0.07 ± 0.02 0.05 ± 0.01 0.05 ± 0.01
Amount of FA (%) 0.86 ± 0.06 1.00 ± 0.09 0.74 ± 0.12 0.72 ± 0.04  
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PAH effects on lipid metabolism and membrane remodeling 
In this investigation we found minor but significant differences between the FA profiles in liver and 
muscle between the control fish and the oil and PAH treated fish. 
The lower amount of long chain MUFA in the liver of PAH treated fish suggests an increased need of 
energy in this fish and selective mobilization of FAs for catabolism. However, this effects is not so 
high that it resulted in lower lipid content in the liver or reduced liver size. The lower amount of 22:6 
(n-3) found in the liver of the PAH treated fish could be a result of increased oxidative stress and lipid 
peroxidation (Valavanidis et al. 2006), but we did not observe similar effects on other highly 
unsaturated PUFAs (22:5 (n-3) or 20:5 (n-3)). Therefore, it seems unlikely that this observation is a 
result of increased degradation of PUFA. The effects seen in the muscle samples after one month 
with higher levels of SFA and MUFA and lower levels of PUFA in the PAH exposed fish could suggest 
modification of the membrane composition to compensate for increased membrane fluidity (Liland 
et al. 2014;Meier et al. 2007;Tekpli et al. 2010). But after two-month exposure (and one week 
recovery), we found higher levels of long chain PUFAs (20:5 (n-3), 22:5 (n-3), 22.6 (n-3)) which does 
not support this mechanism. It is also not likely that the muscle cells will experience high 
concentration of heavy PAHs, as no PAHs or PAH metabolites were detected in the liver or the bile. 
The overall effects on FA profiles are small, but it shows that the PAH and oil exposure effect the lipid 
composition in the haddock liver and muscle. In the present project, we have only analyzed total FA 
profile in the whole tissue. To get a better understanding of the mechanism behind the lipid effects 
one would need to do more detailed lipid analysis and study the FA profiles in the different lipid 
classes. 
However, the results of our lipid analysis do not support the hypothesis of Balk et al., (2011) that 
exposure for PAH and oil compounds is responsible for the increased levels of 20:4 (n-6) and reduced 
levels of (n-3) PUFA (=> lower (n-3)/(n-6) ratio) that were reported in muscle of cod and haddock 
collected at the Tampen area compared with references fish from Egersund bank. Bratberg et al., 
(2013) also did not find changes in the (n-3)/(n-6) ratio in liver phospholipids from cod that were 
exposed for five weeks with weathered crude oil (1.6 or 82 mg oil/kg fish). Investigations from the 
condition monitoring (Grøsvik et al. 2012) have found similar the differences in the FA composition of 
haddock as Balk et al., (2011) between Tampen and Egersund bank in 2008 and 2010, but not in 
2011. The data from the condition monitoring suggest that the difference in FA profile originate from 
the diet and not exposure. FA analysis of stomach content showed similar differences in the (n-3)/(n-
6) ratio as there were in the haddock tissue and the facts that this differences also were seen in the 
neutral lipids (the energy storage lipids) in the haddock liver also points to a diet effect. The haddock 
is an opportunistic predator that feeds on a very diverse variety of benthic invertebrates and fish 
(Schuckel et al. 2010;Tam et al. 2016). The large numbers of offshore platforms at the Tampen area 
may change the benthic communities and thereby the food availability of local haddock (Fujii 2016). 
We plan to publish all the lipid data from the condition monitoring surveys this year and new lipid 
and stomach content data from haddock collected from the whole North Sea (30 stations in 2013) 
are in progress.  
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3.9 Histopathology and liver damage 
At the end of exposure we observed fish with significant grossly visible liver damage (necrosis, areas 
of swelling and fluid-filled cysts) mainly in the PAH groups, but also in the PW- and oil exposure 
groups. One should be very careful in drawing conclusions from this kind of macroscopic observation, 
but they suggest that the PAH treatments resulted in damage to liver physiology and tissue structure, 
and a histopathological evaluation was therefore prioritized for further studies. At the end of 
exposure 10 % (2 out of 20 fish) in the PAH group contained large areas of what appeared to be 
necrotic tissue, and after one week of recovery the possible necrotic tissue was also seen in the PW 
group (2 out of 10 fish). In the PAH group there were found fish with large fluid-filled cysts (2 of 10 
fish) and one fish exhibited a significant mass or nodule/tumor which could not be confirmed by 
histopathological examination. Because of the low number of fish that were sampled from each time 
point (22.04 and 29.04) is difficult to predict if the frequencies of liver damage were representative 
for the whole group. After a two-month recovery on clean food 31-35 fish were sampled, and only a 
few fish (≈3%) were observed with clearly visible gross liver lesions. This either suggests that the 
number of affected fish in the previous samples were over-represented or that the exposed haddock 
were capable of repairing the grossly visible liver lesions.   
Table 11. Numbers of fish with visible liver damages. 
 
 
 
 
22.04.2014 29.04.2014 19.06.2014
Control 0 0 0
PW 0 2 of 10 1 of 35
Oil 0 0 2 of 31
PAH 2 of 20 3 of 10 1 of 33
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Figure 33. Examples of visible liver damages in
PAH (A and C) and PW (B) treated haddock.
 
Samples were taken randomly from the liver and fixed for histopathological examination with the 
goal of detecting various potentially neoplastic or other non-neoplastic lesions. The samples were 
analysed at IRIS as “blind” measurement and the results were further critiqued or confirmed by a 
detailed histopathologic examination by Mark Myers (a world leading histopathologist formerly of 
NOAA Fisheries, and now of Myers Ecotoxicology Services, LLC, both in Seattle WA). In the original 
dataset from IRIS there were reported large amount of necrosis in all samples (>50 % in both control 
and exposed groups). However, the re-examination and analysis by Myers suggested that the vast 
majority of these observations were the result of postmortem (PM) autolysis and necropsy-related 
tissue trauma. Histopathological studies can be difficult and there is always a risk of misdiagnoses 
(Wolf et al. 2015), therefore a double evaluation as here performed is recommended. 
The histopathological examination confirms the macroscopic observation showing increased necrosis 
and inflammation in the PAH treated fish at the end of the two-month exposure and also after one 
week recovery. After two-month recovery fish with necrosis were not found, and only a few 
differences in the liver histopathology were detected among the different treatment groups. These 
results suggest that the haddock have a high capacity to repair previously caused liver damage.   
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4/22/2014 C 100 67 11 0 0 0 0 0 0
4/22/2014 PW 100 56 0 0 0 0 0 0 0
4/22/2014 Oil 89 56 22 0 0 0 0 0 0
4/22/2014 PAH 100 67 0 0 0 11 22 0 11
4/29/2014 C 100 56 33 0 0 0 0 0 11
4/29/2014 PW 100 56 0 22 0 22 22 0 0
4/29/2014 Oil 100 67 0 11 0 0 0 0 0
4/29/2014 PAH 100 67 0 44 11 44 33 0 33
6/19/2014 C 100 78 11 0 0 0 0 0 0
6/19/2014 PW 100 67 11 0 0 0 0 0 11
6/19/2014 Oil 100 56 11 0 0 0 0 0 0
6/19/2014 PAH 100 67 22 0 0 0 0 0 11
Percentage of abnormalities (% individuals affected)
 
Table 12. Histopatological examination of liver for the different treatment groups after two months 
of exposure (22/4), one week of recovery (29/4) and two months of recovery (19/6). Nine fish were 
examined from each group each time. 
 
Figure 35. Examples and description of the histopathological alteration. 
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3.9 Vertebral malformation 
As part of an ongoing VISTA/NFR project (Meier et al., 2012) we wanted to use fish from the Statoil-
haddock experiment to establish background levels of vertebral malformation. These fish were 
sampled at the end of exposure (22.04.2014) and x-ray pictures were taken of 20 fish from each 
group. 
To our surprise there were clear differences in the frequencies of bone malformation between the 
different treatment groups. It is well known that oil exposure on early life stages severely affects the 
bone formation (Carls et al. 1999), but similar effects has not been documented in adult or juvenile 
fish (Danion et al. 2011). Vertebral bone mineralization, however, has been suggested as a biomarker 
of PAH pollution in marine fish (Danion et al. 2011) and our preliminary result shows that this 
mechanism may be very interesting to study in future investigations.  
Table13. Frequency of malformation in PAH exposed haddock. From each group20 fish were examined. 
 
 
 
 
 
Figure 35. X-ray picture of haddock from Control (A), PAH (B) and oil (C and D). The picture shows different 
examples of vertebral malformations; deformities in vertebral 25-27 (B), 34-36 (C) and 36-39 (D).   
 
Number of fish with vertebral malformation (%) malformation
Control 1 5
PW 4 20
Oil 6 30
PAH 6 30
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IV. Discussion  
There are at least two main sources of PAH that fish can be exposed for in the open sea, small 2-3 
ring PAHs with a petrogenic origin and larger 4-6 ring PAHs of pyrolytic origin. The route of exposure 
may be uptake directly from the water, uptake from contaminated sediments or orally through the 
food chain. All three exposure routes may be relevant for haddock that are a bottom living fish, 
finding its food in or just above the sediments. In this experiment, we have focused on oral exposure, 
comparing three different PAH compositions that intend to represent three different sources, 2 rings 
PAHs extracted from PW, 3 and 4 rings PAHs obtain from crude oil distillation fractions, representing 
oil contaminated drill cuttings, and heavy 4-6 ring PAHs representing background in sediments 
contaminated from atmospheric fallout and urban runoff. 
Historically, the analysis of DNA adduct profiles in fish exposed to environmental pollutants 
represents an important approach in environmental risk assessment since Dawe et al. claimed in 
1964 that bottom feeding fish were “useful indicators of environmental carcinogens” (Dawe et al. 
1964). DNA adducts are now considered as a crucial biomarker of exposure in human and sentinel 
organisms, especially for their early emergence after a genotoxic exposure, which may play a key role 
in establishing a mode of action for cancer (Pottenger et al. 2009). Because of its high sensibility and 
versatility, the method of 32P postlabelling has been applied to environmental fish studies as early as 
1980s, few years after the first publication of the method (Randerath et al. 1981). Thus, in 1987, 
Dunn et al. measured significant DNA adduct levels in livers of wild Brown bullheads sampled from 
different sites in the Buffalo and Detroit Rivers, in association with exposure of fish to high 
concentrations of PAH (Dunn et al. 1987). Since these early works, numerous fish species were 
studied, in a large panel of applications (laboratory and field studies). Laboratory studies from 
isolated subcellular organelles (like hepatic microsomes) and cells in culture to the entire organisms 
allowed for better understanding of the relation between the exposure to pollutants as PAH (isolated 
or in mixtures), and certain biological adverse effects including genotoxicity by DNA adduct 
formation (Varanasi et al. 1989a;Wessel et al. 2012). In the late 1980s, hepatic DNA adducts related 
to BAP were for the first time detected in English sole exposed to this PAH in laboratory (Varanasi et 
al. 1989b), supporting the hypothesis of the causal relationship between fish exposure to PAH 
pollutants and hepatic neoplasms that are frequently described in this species at Puget Sound. 
A large number of studies of oral exposure of PAHs of fish have been carried out. Bravo et al. (2011) 
exposed juvenile rainbow trout with feed containing a mixture of heavy PAHs (10 high molecular 
weight PAHS, 4-6 rings; all of this are also present in the mixture we have used in the haddock 
experiment). The exposure doses used in their study (Low dose=0.66 mg PAH/kg fish/day and high 
dose=7.8 mg PAH/kg fish/day) are related to the levels of PAH found in the stomach of wild salmon in 
the Puget Sound (WA, US) (Bravo et al. 2011). The fish were feed for 50 days and followed for 21 
days of recovery period (fasting). The low dose in that investigation is therefore comparable to our 
haddock experiment (our doses for the PAH group were 0.65 mg PAH/kg fish/day). They analyzed 
bile metabolites by HPLC-fluorencence detection; using 260/380 nm (PHE-type) and 380/430 nm 
(BAP-type). They found a strong induction at both wavelengths after 3 days of exposure and with a 
maximum at day 14. The detection of PAH bile metabolites were high during the whole exposure 
period and remained surprisingly high during the 21 days of fasting. The authors suggested that this 
lack of decline in the recovery period may be explained either by the bile not being released in 
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fasting fish or a recirculation by intestinal reabsorption. This experiment documented that the heavy 
PAHs were taken up from the feed and metabolized and excreted through the bile. The presence of 
high levels of bile metabolites is opposite to the observation in the present haddock study.  As 
biomarkers for AhR activation Bravo et al. analyzed hepatic microsomal ethoxyresorufin-O-
deethylase (EROD) activity and CYP1A staining (antibody detection) in the liver. They found a 
significant increase in CYP1A protein in the liver from both doses, but only increased EROD activity in 
the high dose. The Comet assay was used to detect gene damage in blood cells, and a maximum 
amount of DNA strand breaks was found after 14 days of exposure in both low and high treatments 
groups. After 28 days of exposure there were still a significant increase in DNA strand breaks in the 
exposed groups compared with control, but in the low dose group the amount was only ¼ of that 
measured in the same group after 14 days exposure. At day 50 there were no significant increase in 
DNA damage in either of the exposure groups compared with the control. This interesting result 
shows a reduction in toxic response to long-term PAH-exposure in rainbow trout. This indicates that 
rainbow trout also can adapt through a protection system against chronically oral exposure of PAHs. 
Another interesting result from this study is the documentation of decreased survival in pathological 
challenge experiments in the PAH exposed trout (both doses) (Bravo et al., 2011). Effects on the 
immune system and increased disease susceptibility are parameters that could be interesting to 
include in the water column survey. 
Ericson et al (1999,) exposed Northern pike (Esox lucius) to multiple oral doses (6 mg/kg fish) of 
single compounds or mixtures of BaP, BkF or 7H-dibenzo[c,g]carbazole (DBC) and measured DNA 
adduct in liver, gills, brain and intestine. The fish were exposed to 5 doses with 12-day intervals 
between each dose and the fish were followed 78 days for recovery after end of exposure (given at 
day 59) (Ericson et al. 1999). Rapid uptake was observed and DNA adducts were detected in the liver 
one day after the first dos and in the intestine after three days. The levels of DNA adducts after 
multiple doses was 3 times higher in the intestine (347±17 nmol adduct/mol normal DNA) that in the 
liver (110±9 nmol adduct/mol normal DNA). The clearances rate of DNA adduct was slow and after 
78 days recovery only a 30 % reduction of DNA adducts in the intestine and no reduction in the liver 
were noted.  
High accumulation of non-extractable BaP (=> covalent bound) has also been reported in Atlantic 
salmon (Salmo salar) (de Gelder et al. 2016) and polar cod (boreogadus saida) (Bakke et al. 2016) 
after a single oral dose of BaP and Phe. Using radioactive marked 14C-BaP and 14C-Phe it was found 
that BaP mainly accumulated in the intestine, while Phe was found in higher concentration in the 
liver and the bile. This shows that there may be differences in the metabolic pathways for heavy 
PAHs (>4 rings) and small PAHs (2-3 rings). 
Several other studies have also suggested that the amount of BaP (5 ring PAH) that reach the liver is 
much lower in oral exposure compared with exposure through intraperitoneal injection due to high 
accumulation and metabolism of BaP in the intestine, Sea Bass (Dicentrarchus-labrax) (Lemaire et al. 
1992), English sole (Parophrys vetulus), starry flounder (Platichthys stellatus) (Varanasi et al. 1986) 
and rainbow trout (Hendricks et al. 1985).  
Similar comparisons between oral and waterborne exposure of BaP in Nile tilapia (Oreochromis 
niloticus) have shown that the induction of CYP1A detoxification are very different distributed though 
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out the body after the two different exposure routes. In the oral exposed fish, only increased EROD 
values in the intestine were found, while the water exposed fish has EROD induction in the gill and 
the liver (Costa et al. 2011). 
Taken together there are evidences that large parts of the metabolism of 5 rings PAHs are located to 
the intestine and that induction of the intestinal detoxicification system are a very important 
protection against oral exposure of this compounds (Fang and Zhang 2010;Uno et al. 2004). 
It is likely to believe that during chronic exposure in our experiment, the detoxification system in the 
digestion system have been strongly induced. High first-pass metabolism in the intestine may explain 
why we do not find higher effects in the liver after two months of exposure.  
 
 
V. Conclusion and advice for further investigation 
We have conducted a successful oral exposure experiment where juvenile haddock have been 
exposed for different PAH mixtures representing different pollution sources; PW, oil polluted 
sediments and long-transported background pollution.  
A number of key questions were addressed: 
1. Does oral exposure to PAH induce DNA-adduct in haddock? 
Strong induction of DNA adducts in the liver (PAH>>Oil>PW) three days after only one 
exposure dose were found. All PAH mixtures increased the levels of DNA adducts in the 
haddock livers. This shows that PAHs are taken up from the food and readily metabolised 
into reactive metabolites that bind the DNA in the liver, and that a single oral dose is 
sufficient to induce DNA adducts by 3 days after exposure. 
2. What is the time effect in DNA-adduct formation during chronic exposure, and how fast 
will fish recover? 
The levels of DNA adduct dropped dramatically (10 fold) after one month and two months of 
exposure compared with the first observation after three days of exposure. The amount of 
DNA adducts after two months of exposure is significantly higher in all treatment groups 
compared with the control fish, but it can only be classified to be mildly induced. The DNA 
adduct levels are similar to what have been found in wild fish in the field, and fish that have 
been water exposed to PW and crude oil. The two-months of recovery on clean food did not 
result in a significant reduction of amount of DNA adduct compared with the levels at the 
end of exposure. The high reduction of DNA adducts after chronically exposure suggest that 
an induction of a protective first-pass metabolism in the intestine toward heavy PAHs. 
Likewise, most the DNA repair system have been active in clearances of damaged DNA in the 
liver after the first acute raise, but following the fish into a two months recovery period did 
not show any decline of DNA adduct. This show a long lifetime of DNA adducts.    
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3. Does different PAH give different DNA adduct patterns from the 32P-postlabelling method, 
and can the “spot position” be used to identified the source of PAH exposure? 
It was not possible to distinguish between the DNA adduct spot positions from the different 
PAH treatments. From the fish that were injected with heavy PAHs we found 16 different 
spots, however, in the oral exposed fish only three spots with high frequency were found. 
Spot 1 is the dominating spot and this is present in all treatments groups, but also in several 
fish in the control group. This spot1 is either formed from a common electrophile metabolite 
or more probably to chemically related adducts that are not separated by the thin layer 
chromatography system. 
The present experiment clearly documents that the P32 postlabelling is a very sensitive 
detection method but it is not able to give any structure information of the DNA adduct and 
the PAH sources responsible for its formation. The UHPLC-MS/MS analysis, on the other 
hand, shows a great potential of both targeted analysis (identification with synthetic 
standards) or screening of unknown PAH-DNA adduct. To get any progress in the DNA adduct 
work on wild fish, it is our opinion that mass spectrometry methods should be used. This will 
require method development and more experimental work. 
  
4. How are DNA adducts correlated with other endpoints; PAH bile metabolites and CYP1A 
induction? 
No correlations between the concentrations of PAH bile metabolites and the levels of liver 
were found. The study suggested that the GC-MS method used at IMR to analyse mono-
hydroxylated PAH metabolites is not covering the dominating metabolites and new methods 
should be established.  
CYP1A was induced in liver of the oil and PAH groups, but not in the PW exposed fish. This 
correlated with induction of DNA adducts where the PAH and oil groups had the highest 
levels, but elevated DNA adducts was also found in the PW groups, so induction of CYP1A 
does not seem necessary for formation of DNA adducts in this fish. The relative low induction 
of CYP1A in the liver and the low presence of bile metabolites in the group exposed for large 
4-6 rings PAHs suggest that large parts of the detoxification are happing in the ingestion 
systems. The presence of relatively high amount of 2 and 3-rings PAHs in the liver, suggest 
that small PAH is not metabolised in the intestine and that the liver will be the target tissue 
for these compounds.  
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Important questions that should be answered before scientific publication of this data: 
 
1. The very high levels of DNA adducts found after 3 days (and a single dose) was only analyzed 
in 2 fish from each treatment groups and was unexpected. At least 8 more fish from each 
group for DNA adducts should be examined, so one can present the data with a statistical 
analysis.  
 
2. Samples taken after 10 days of exposure have not been analyzed at all. It would be 
interesting to include this sampling point into the investigation to get a better resolution of 
the time-effect on DNA adduct formation observed. The parameters that should be included 
are; DNA adducts, bile metabolites, CYP1A qPCR. 
 
3. The surprising results showing the strong reduction in DNA adducts over time suggest 
intestinal detoxicification and protection. Samples have been collected of the intestine and 
we suggest that DNA adduct and CYP1A induction is measured from the fish after two-
months of exposure. This analysis can contribute with important knowledge of haddock 
capacity to protect itself against food borne PAH pollution. It will add novelty to the work 
and it can be important information for the water column survey, and suggest that sampling 
of intestine should be included in the program to investigate the route of exposure in wild 
haddock.  
 
4. Bile samples should be re-examined for dihydroxylated and other more polar metabolites. 
This will be done by LS-MS/MS at NOAA (USA) and at IMR using preparative HPLC and GC-
MS/MS. Validation of a new method for bile metabolites is very important for the field work 
IMR are doing and this work will be funded internally at IMR. 
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VII. Material and Methods 
 
Chemicals 
PAHs; Fluoranthene (FL), Pyrene (PY), Benz[a]anthracene (BAA), Chrysene (C), Benzo[b]fluoranthene 
(BBF), Benzo[k]fluoranthene (BKF), Benzo[e]pyrene (BEP), Benzo[a]pyrene (BaP), Perylene (Per), 
Dibenz[a,h]anthracene(DBA), Indeno(1,2,3-cd)pyrene (IND), Benzo[ghi]perylene (BP) were all obtained 
from CHIRON (Trondheim, Norway). 
 
For the injection experiment the PAHs was dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich, 
Oslo, Norway) to a concentration of 4 mg/ml. 
 
For the food mixture, the PAH mixture was dissolved in fish oil (NOFIMA, Bergen, Norway) 
 
Experimentental food 
To prepare exposure mixtures that had the natural high complexity of PAH isomers found in PW and 
oil, we used extract of PW from Statfjord A and a distillation fraction of Gullfaks oil (delivered from 
Mongstad by Britt Steine). The distillation fractions were: Fr1 (240-320 °C); Fr2 (320-375°C); Fr3 (375-
400 °C). 
PW was collected at Gullfaks and sent with boat to IRIS Stavanger. The extractions were done in a big 
1000 L polyethylene tank. Oil compounds from PW were extracted with 20 L cyclohexane. 
Cyclohexane was removed by evaporation and the PAH content in the PW extract analysed on GC-MS. 
Table M1 shows the different compositions of the PAH sources used in the feed. The PAH profiles in 
the feed are given in Figure 3/Table 3 and Table A3. The PW, Oil and PAH mixtures were dissolved in 
fish oil mixed into the fish pellets. The fish feed (4 mm pellets) were made by NOFIMA, Feed 
Technology Centre, Bergen (Table M1 and Table M2). 
Table M1. Composition of PW, Oil and PAH mixtures used in the feed. 
Composition PAH content (% of weight)
PW mixture 60 g PW extract + 6 g oil Fr1 1.1
Oil mixture 30 g oil Fr2 + 36 oil Fr3 + 0.04 g pyrene (Standard) 1.5
PAH mixture 12 PAH standards (20-212 mg) 100
Composition in feed
PAH content i feed. 
Measured by GC-MS
PW feed 28 g of PW mixture to 13 kg feed 31 mg PAH/ kg feed
Oil feed 27 g Oil mixture to 13 kg feed 45 mg PAH/ kg feed
PAH feed 976 mg PAH to 13 kg feed 65 mg PAH/ kg feed  
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Table M2. Composition of the fish pellets (made at NOFIMA, Feed Technology Centre, Bergen) 
 
Haddock husbandry 
The Juvenile haddock used in the experiment were produced at Austevoll research station from a wild 
broodstock population of 61 mature individuals collected February 2013 at spawning grounds in the 
Austevoll area, on the west coast of Norway. The broodstock were kept in two 7000 L tanks and they 
spawn voluntarily in capacity spawning. Fertilized eggs were collected, transferred to indoor egg 
incubators until hatching. The haddock larvae have been raised on natural plankton (mainly copepod 
of Acartia longiremis, harvested from the marine pod system “Svartatjern (Van der Meeren et al., 
2014) until the larvae started to take dry feed and were fed marine pellets. The fish have been grown 
on a natural light regime and with a water temperature of 8°C. 
 
The 17th January 2014 were 440 fish (125±35 g wet weight) marked individually with electronic tags 
and evenly distributed between five circular tanks (3 m diameter, 7 m3). The fish were feed ad libitum 
with automatic feeding unit 5 times a week until the exposure experiment starts.  
 
The exposure experiment started 14th February and lasted till 22th April. A group of fish from each 
treatment were kept for two months until 19th June to look for long-term effects. The exposure 
experiment has been conducted as planned and 420 haddock were sampled. 
Ethics Statement 
All animal experiments within the study were approved by NARA, the governmental Norwegian 
Animal Research Authority (http://www.fdu.no/fdu/, reference number FOTS ID 5924). All methods 
were performed in accordance with approved guidelines. All fish were killed before sampling with a 
high dose MS-222 (tricaine methanesulfonate, TS 222, Sigma-Aldrich). The animals were monitored 
daily, and dead fish were removed. There was low mortality during the experiment, totally 19 fish died 
(<5%) and without any correlation to the exposure. 
The Austevoll Aquaculture Research station has the following permission for catch and maintenance of 
Atlantic haddock: H-AV 77, H-AV 78 and H-AV 79. These are permits given by the Norwegian 
Directorate of Fisheries. Furthermore, the Austevoll Aquaculture Research station has a permit to run 
as a Research Animal facility using fish (all developmental stages), with code 93 from the National 
IACUC; NARA.  
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Experimental design 
The exposure experiment was started 14th February and lasted till 22th April. Approximated 45 fish 
from each treatment group were keep for a recovery study and feed an uncontaminated diet until the 
19th June. The control fish weights at start of experiment were 147±31 g and at experiment end 
336±57 g. The fish were feed four different diets with automatic feeding unit 5 times a week with a 
ratio corresponding 10 g pellets/kg fish/day (1 % of body mass per day). This correspond a daily dose 
of PW treatment group: 0.31 mg PAH/kg; Oil treatment group: 0.45 mg PAH/kg and PAH treatment 
group: 0.65 mg PAH/kg. 
Samples one week after end of exposure and the remaining fish were transferred to one common tank 
and maintained for one month until 19th June and sampled to study long term effects.  
The experiment was carried out on juvenile haddock (100-250 g) and the fish were exposed to 
different hydrocarbon mixtures through the feed. The fish were marked with electronic tags and held 
in five circular tanks (3 m diameter, 7 m3). The fish were feed with automatic feeding unit 5 times a 
week with a ratio corresponding 10 g pellets/kg fish/day (1 % of body mass per day). This correspond a 
daily dose of PW treatment group: 0.31 mg PAH/kg; Oil treatment group: 0.45 mg PAH/kg and PAH 
treatment group: 0.65 mg PAH/kg. 
Injection experiment 
At the start of the experiment (14.02.2014), 26 haddock were injected with single PAH compounds (2 
fish for each of the 12 heavy 4, 5 and 6 ringed PAH compounds used in the PAH mixture) and sampled 
after two days. The PAHs were dissolved in DMSO and fish oil to a concentration of 4 mg/ml and each 
fish were injected in the abdominal cavity with 1 µl/g fish corresponding to a dose of 4 mg/kg fish. The 
injected fish will be used to generate bile metabolite and DNA adduct “library”.  
Sampling. 
Six samplings of fish were preformed during the experiment (Table M3).  
We sampled for two projects: Statoil-haddock and iNEXT (a PhD project at IRIS, Phd candidate; 
Karianne Skogland, supervisor; Daniela Pampanin).  
All samples were frozen down on liquid nitrogen and stored at – 80° C. Samples to IRIS have been sent 
to Stavanger and the Statoil-Haddock material are at IMR in Bergen. 
Table M3. Samplings time and number of fish. 
 
 
 
Samples of several tissues were taken (Blood, bile, liver, muscle, brain, intestine, heart and whole fish) 
(Table M4). The samples of intestine, heart and brain will not be included in the analytical program of 
this application. The material will be kept at IMR for future studies. 
Exposure groups 17.02.2014 24.02.2014 24.03.2014 22.04.2014 29.04.2014 19.06.2014
Control 10 10 15 20 10 36
PW 10 10 15 20 10 35
Oil 10 10 15 20 10 31
PAH 10 10 15 20 10 33
Injection (PAH) 25
 61 
 
Table M4. Overview of samples collected from each sampling time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA adduct analyses (32P- postlabelling) 
Detail about the 32P- postlabelling methods are given in report from ADn’tox, Caen, France. 
 
DNA adduct analyses (LC-MS/MS) 
An ultra-high performance liquid chromatography coupled to tandem mass spectrometry (UHPLC 
MS/MS) method for the detection of DNA adducts, currently under development, was first applied to 
a sample exposed for PAH mixture for 2 months (n°38). This sample contain high level in DNA adducts 
as revealed by its 32P postlabelling analysis (40 nmol adducts/mol normal DNA). The method that has 
been developed by the ADn’tox partner PRISMM (an academic platform of the University of Caen, 
France) is suitable for detection of the major BaP adduct: benzo(a)pyrene (BP)-7,8-diol-9,10-epoxide-
N(2)-deoxyguanosine (BPDE-dG) in the MRM (Multi Reaction Monitoring) mode, but can also be used 
for the pre-screening of multi-adduct detection in the PNL (Pseudo Neutral Loss) mode. The later 
mode is focused on the loss of the deoxyribose (dR) from the protonated DNA adducts ([M+H-116]+), 
a particular fragmentation common to all nucleosides in MS, including the parent dG DNA adducts.  
As for postlabelling, the sampled DNA content is firstly extracted by phenol-chloroform and then 
hydrolyzed with a five enzyme cocktail in individual nucleosides, before the UHPLC separation and 
MS/MS detection.  
 
Code and sample Analysis parameters Statoil haddock IRIS
Bile samples
B1 PAH Metabolits minimum 50 µl
B2 protein-adducts 50-100 µl
Liver samples
L1 DNA addukt (32P-postlabering) 500 mg
L2 DNA addukt (LC-MS/MS) 500 mg
L3 RNA-Seq 500 mg
L4 Lipid -FA 500 mg
L5 ELISA  protein 500 mg
L6 Protein-PAH adduct analysis 500 mg
L7 Histology Sample on fix
Blood samples
P1 protein-adducts 200 µl 
Muscle samples
M1 Lipid 1 g
Brain samples
H1 Lipid whole
Intestine samples
I1 RNA-Seq Inner intestine
I2 Middle intestine
I3 Back intestine
Heart samples (only from 22.04.2014)
HA RNA-Seq Whole heart
Whole fish for x-ray (only from 22.04.2014)
X-ray Vertebral body malformations Whole fish
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Analysis of PAH metabolites in fish bile (GC-MS) 
Bile (100 μl) was diluted in 200 μl sodium acetate buffer (0.01 M, pH 5). 36 μl β-glucuronidase (115600 
units/ml) were added, and samples were incubated at 37°C for 2 hours. Surrogate internal standard 
(SIS) including two deuterated hydroxyl PAH, 1-naphthol-d7 and 1 hydroxypyrene-d9, were added to 
the solution which was then further diluted with 2 ml acetic acid (0.1 %). The mixture was then loaded 
onto Oasis (HLB) SPE column (4 cc volume), previously preconditioned with 1 ml methanol and 1 ml 
acetic acid (0.1 %), successively. The column was rinsed with 3 ml acetic acid (0.1 %) and dried for ½ 
hour under vacuum. The analytes were extracted by 4 ml of methanol. The extract was then 
evaporated to ca. 0.2 ml under a nitrogen stream (40°C). The eluate was derivatizated with 
pentafluorobenzoyl chloride as described elsewhere (Boitsov et al. 2004) and the samples 
concentrated to 0.5 ml hexane solution under a nitrogen stream (40°C). All samples were analysed by 
GC-MS in selected ion monitoring (SIM) mode using negative chemical ionization (NCI).  
 
Table M5. Mass spectrometric analysis, the quantifier ion (m/z) and retention time of the different 
PAH-OH (as pentafluorobenzoate derivatives) that were scanned for in SIM mode (methyl-naphthols in 
cursive are coeluating on the GC)  
RT Quantifier ion (m/z)
1-Naphthol 18,23 338
2-Naphthol 18,80 338
7-Methyl-1-naphthol 19,55 352
8-Methyl-2-naphthol 19,55 352
2-Methyl-1-naphthol 19,74 352
3-Methyl-1-naphthol 19,82 352
6-Methyl-1-naphthol 20,14 352
3-Methyl-2-naphthol 20,30 352
7-Methyl-2-naphthol 20,73 352
6-Methyl-2-naphthol 20,85 352
4-Methyl-1-naphthol 20,97 352
5-Methyl-1-naphthol 21,03 352
1-Methyl-2-naphthol 21,06 352
4-Methyl-2-naphthol 21,23 352
5-Methyl-2-naphthol 21,38 352
2-Hydroxyfluorene 24,82 376
9-Hydroxyfluorene 28,32 167
4-Hydroxyphenanthrene 29,51 388
3-Hydroxyphenanthrene 31,79 388
1-Hydroxyphenanthrene 31,85 388
9-Hydroxyphenanthrene 32,27 388
2-Hydroxyphenanthrene 32,66 388
1-Hydroxypyrene 38,61 348
2-Hydroxychrysene 45,58 438
SIS
1-Naphthol-d7 18,13 345
1-Hydroxypyrene-d9 38,49 356  
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Analysis of PAH metabolites in bile (fix wavelength fluorescence method) 
Analysis of bile samples were diluted 1:1600 in methanol: water (1:1). Slit widths were set at 2.5 nm 
for both excitation and emission wavelengths, and samples were analysed in a quartz cuvette. All bile 
samples were analysed by FF at the wavelength pairs 290/335, 341/383 and 380/430 nm, optimised 
for the detection of 2-3 ring, 4-ring and 5-ring PAH metabolites, respectively. The fluorescence signal 
was transformed into pyrene fluorescence equivalents through a standard curve made by pyrene 
(Sigma St Louis, USA). Pyrene was measured at the same fluorimeter, with the same cuvette, same 
solvent, and with the same slit settings as the bile samples. It was, however, measured at the optimal 
wavelength pair of pyrene, 332/374 nm (excitation/emission). The concentration of PAH metabolites 
in bile samples was expressed as μg pyrene fluorescence equivalents (PFE)/ mL bile. 
Analysis of PAH in haddock liver (GC-MS/MS) 
Extraction of haddock liver samples (0.4-0.5 g) was performed as described in Sørensen et al (2016). 
After addition of surrogate standards (naphthalene-d8, biphenyl-d8, acenaphtylene-d8, anthracene-
d10, pyrene-d10, perylene-d12 and indeno[1,2,3-cd]pyrene-d12; 20 ng/g sample), the samples were 
homogenized in n-hexane-DCM (1:1 v/v, 3 mL), followed by addition of sodium sulphate (150 mg), 
vortex extraction (30 s) and centrifugation (2000 rpm, 2 min). The supernatant was collected and the 
extraction repeated twice. The combined organic extract was concentrated to ~0.5 mL, filtrated and 
volume adjusted to 1 mL.  
The samples were further subjected to purification to remove co-extracted lipids. For the removal of 
triacylglycerids and phospholipids, gel permeation chromatography was applied. An Agilent 1220 
Infinity series LC was used coupled to a diode array detector (DAD) for retention time monitoring. GPC 
columns were supplied by Waters (Envirogel GPC cleanup, 300×19 mm). 500 µL samples were injected 
and eluted using dichloromethane at a flow rate of 5 mL/min. The PAH fraction was collected from 10-
14 minutes. The volume of the eluent was adjusted to 1 mL prior to clean-up by normal phase SPE 
(Agilent Bond Elut SI, 500 mg) to remove remaining polar lipids (cholesterol, free fatty acids). The 
extract was eluted with dichloromethane in n-hexane (1:9, v/v, 6 mL). Immediately prior the analysis, 
the volume of the purified extract was reduced to 100 µL under a gentle stream of N2.  
An Agilent 7890 GC coupled with an Agilent 7010 triple quadrupole MS fitted with an EI source and 
collision cell was used for the analysis. Two DB-5MS UI GC-columns (15 m × 0.25 mm x 0.25 µm) were 
coupled in series through a purged ultimate union (PUU). The carrier gas was helium at constant flow 
(1.2 mL/min). Samples (1µL) were injected at 280 °C splitless. The oven temperature was held at 60 °C 
for 1 min, then ramped to 120 °C by 40 °C/min and finally ramped to 310 °C by 5 °C/min. The 
temperature was held at 310 °C for 5 minutes, while the first column was back-flushed. The transfer 
line temperature was 280 °C, the ion source temperature was 230 °C and the quadrupole 
temperatures were 150 °C. The EI source was operated at 70 eV. N2 was used as collision gas at a flow 
of 1.5 mL/min and helium was used as a quench gas at a flow of 4 mL/min. An 11-level calibration 
curve was prepared (0.1-250 ng/mL) and fitted with quadratic regression for the quantification of 
analytes after normalization to the response of internal standards. 
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qPCR  
Quantitative PCR assay was carried out starting from homogenate liver samples through RNase-Free 
DNase Set by Qiagen. Before RNA cleanup as described by RNeasy Mini Handbook (Qiagen, 2012), 
total RNA was extracted from all the samples using a specific method for liver tissue using trizol (1 ml 
for each sample), 200 μl chloroform, 1.2 M sodium citrate, isopropanol and ethanol 75% (35 ml 
absolute ethanol added to 50 ml DEPC water).  
 
Primers selected were CYP1A, AHR (Aryl hydrocarbon receptor repressor), AHRR (Aryl hydrocarbon 
receptor repressor), GADD45A (growth arrest and DNA-damage-inducible, alpha), GADD45G, p53 (part 
of p53 pathway, selected to understand whether they may be activated due to DNA damage after 
PAHs exposure). Real time qPCR was performed referring to Fast SYBR Green Master Mix Protocol 
(Thermo Fisher Scientific). The plate was read using ABI 7900HT Fast Real Time PCR System at 95° for 
cDNA denaturation and at 60° for primers attachment for 40 cycles. 
 
 
Table M6. PCR primers, contig names and amplicon sizes. 
Gene 
ID 
Gene name Marker for Contig name Forward primer Reverse primer 
Amplic
on size 
(bp) 
CYP1A1 
Cytochrome P450, family 1, 
subfamily A 
Detoxificatio
n 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_3768  CTGCGCCACAAAAGACACAT 
TTGAAGGTGGACGGTTCCT
T 120 
AHRR 
Aryl-hydrocarbon receptor 
repressor 
Detoxificatio
n 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_92712  AGCCAGACGCTGAACCTCAT 
ATGCCGTGACCCTTGAACT
C 122 
p53 Tumor protein p53 DNA damage 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_2079  
CCTGCTGAACTTCATGTGCA
A 
CCGAGAACATGCCCTTCAG
A 102 
GADD4
5A 
growth arrest and DNA-
damage-inducible, alpha DNA damage 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_13955  ACGGTGTCAAAGGCAATCG 
CTGGGTCCGCATTGAGAGA
T 103 
GADD4
5G 
growth arrest and DNA-
damage-inducible, gamma DNA damage 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_5185  GTGCGCGTCAACGATATTGA 
AAGGGTCTTTCCATGGGTT
TG 121 
EEF1A 
Eukaryotic translation 
elongation factor 1 alpha 1 RefGen 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_221  CACATCGCCTGCAAGTTCAA 
GGCTTGCTTGGGATCATGT
T 128 
UBA52 
Ubiquitin A-52 residue 
ribosomal protein fusion 
product 1 RefGen 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_5918  
TGAGGTCGAACCCAGTGAC
A CTGCTTGCCAGCGAAGATC 103 
ACTB Beta actin RefGen 
>Soerhus-mRNA-2-dpf-
1_CGATGT_L001_R1_001
_(paired)_contig_877  
ACAGCCGAGCGTGAGATTG
T 
TCGGGAAGCTCGTAGCTCT
TC 125 
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RNAseq 
RNAseq analyses have been performed on liver from 4 individual haddock per treatment sampled 
after 2 months (22nd April, 2014) of oral exposure to feed spiked with different PAH profiles 
(resembling oil, produced water and pyrogenic PAHs) followed by two months of recovery with normal 
feed, sampled 19th June 2014. A total of 32 individuals were analysed.  
cDNA library preparation and sequencing was performed by the Norwegian Sequencing Centre (NSC, 
Oslo, Norway) using the Illumina TruSeq RNA Sample Preparation Kit. Using the multiplexing strategy 
of the TruSeq protocol paired end libraries were performed and ran on the Illumina HiSeq 2500.  
High sequence similarity between cod and haddock justified use of the cod gene model as a template; 
the average sequence similarity between mapped haddock reads and the cod reference was 98.4%. 
Further, we chose to use a verified gene model over a reference-free de novo transcriptome approach 
to avoid noise from fragmentation and redundancy from un-collapsed genes resulting in a high 
number of false positives. Thus, the RNA sequencing data was mapped to the coding sequences of the 
cod gene models (Star et al., 2011) using the Burrows-Wheeler aligner (Li and Durbin, 2009). The cod 
gene models were annotated with various resources, including Swiss-Prot, Uniref90, GeneOntology 
and KEGG (Kyoto Encyclopaedia of Genes and Genomes). Samtools idxstat (Li et al., 2009) was used to 
extract number of mapped reads. The reads were normalised by the total number of mapped 
sequences. NOISeqBIO (Tarazona et al., 2011) was used to obtain DEGs between the developmental 
stages (threshold of 0.95). Only genes with 10 reads or more in at least one of the samples were 
included for further analysis. KEGG pathways analysis (Kanehisa et al., 2012) was performed by 
mapping the KEGG annotated DEGs from NOISeqBIO to KEGG pathways as described in the KEGG 
Mapper tool. 
ELISA analyses of CYP1A content in liver 
Buffer for homogenising  
0,1 M sodiumphosphate (NaH2PO4·H2O), 0,15 M potassiumchloride, 1 mM EDTA, 1 mM DTT, 10% v/v 
glycerol, pH 7,4. 
Homogenising of liver and preparation of postmitochondrial supernatant (PMS) 
Approx. 0,5 g liver vas added homogenising buffer (2 ml pr 0.5 g liver) and homogenised with use of 
Potter Elvehjem homogeniser (7 strokes). The homogenate was transferred to Eppendorf vials and 
centrifuged for 20 min at 12.000xg, 4˚C. Samples were stored at -80˚C. 
Measurements of protein content 
Performed according to Bradford (1976). PMS-fraction of fish liver was diluted 1:1000 in dH2O. 50 µl 
of sample (in triplicate) was added ELISA-plate (Nunc 96 wells, flat bottom). 300 µl Coomassie G-250 / 
17% phosphoric acid (1:1) was added the samples and incubated for 5 min. Absorbance was measured 
at 595 nm by plate reader (Tecan SPECTRA Fluor). Protein concentration determined by standard 
curve with bovine serum albumin. 
 
ELISA 
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Performed as described in Nilsen et al. (1998). 1 g total protein added per well, 4 parallels per 
sample, divided on two plates. For measurements of CYP1A1 in cod liver we used monoclonal mouse 
anti-cod CYP1A (NP-7, Biosense, Norway), diluted 1:1000. For CYP1A measurements in haddock, we 
used polyclonal rabbit anti-trout CYP1A (CP-226, Biosense, Norway), diluted 1:1000. For secondary 
antibodies, we used polyclonal goat anti-mouse/rabbit from DacoCytomation, Denmark, diluted 
1:2000. Plates were incubated with TMB substrate for 22.5 minutes before addition of 0.5 M H2SO4 
and absorbance read at 450 nm. 
Preparation of post-mitochondrial supernatant (PMS) fraction for Glutathione S-transferase (GST) 
activity measurement and estimation of lipid peroxidation (LPO) 
Post mitochondrial supernatant (PMS) was obtained according to the method of Ahmad et al. (2000). 
The liver was homogenized, using a Potter homogenizer, in phosphate buffer (0.1 M, pH 7.4). This 
homogenate was divided in two aliquots for LPO and PMS preparation. PMS preparation was 
accomplished by centrifugation in a refrigerated centrifuge at 13,400 g for 20 min (4°C).  
GST activity measurement 
GST activity was determined in PMS fraction, following the conjugation of GSH with 1-chloro-2,4-
dinitrobenzene (CDNB) by the method of Habig et al. (1974) with some modifications. The reaction 
mixture consisted of 1.85 ml sodium phosphate buffer (0.1 M, pH 7.4), 0.050 ml reduced glutathione 
(1 mM), 0.050 ml CDNB (1 mM) and 0.050 ml PMS. Absorbance was recorded at 340 nm (25 °C) and 
expressed as nmol CDNB conjugate formed/min/mg protein (ε = 9.6 x 103 mM-1 cm -1). 
Estimation of LPO 
LPO levels were determined in the liver homogenate by the procedure of Ohkawa et al. (1979) and 
Bird and Draper (1984) with some modifications. Briefly, to 150 μl homogenate, 5 μl of 4% butylated 
hydroxytoluene (BHT) in methanol, was added and mixed well. To this aliquot, 1 ml of 12% 
trichloroacetic acid (TCA) in aqueous solution, 0.90 ml Tris–HCl (60 mM, pH 7.4 and 0.1 mM DTPA) and 
1 ml 0.73% 2-thiobarbituric acid (TBA) were added and mixed well. The mixture was heated for 1 h in a 
water bath set at boiling temperature and then cooled to room temperature and centrifuged at 
13,400 g for 5 min. Absorbance was measured at 535 nm and LPO expressed as nmol of thiobarbituric 
acid reactive substances (TBARS) formed/mg protein (ε = 1.56 x 105 M-1 cm-1). 
Fatty acids analysis 
Collection of small subsamples (20-50 mg) of haddock liver was done while the liver was still frozen to 
avoid “lipid bleading”. Similar small samples (50-80 mg) were taken of the haddock muscle.   
All samples were methylated and the respective fatty acid methyl esters (FAME) were analyzed on a 
HP-7890A gas chromatograph (Agilent, USA) with a flame ionization detector (GC-FID) according to a 
method described in (Meier et al. 2006) with the fatty acid 19:0 as an internal standard. As a 
methylation reagent 2.5 M dry HCl in methanolwas used. The FAMEs were extracted using 2x2 ml of 
hexane. The extracted hexane was diluted or concentrated to obtain a suitable chromatographic 
response. One microliter was injected splitless (the split was open after 2 min), the injection 
temperature was set to 270°C. The column was a 25 m × 0.25 mm fused silica capillary, coated with 
polyethylene-glycol of 0.25 μm film thickness, CP-Wax 52 CB (Varian-Chrompack, Middelburg, The 
Netherlands). Helium (99.9999 %) was used as mobile phase at 1 ml/min in 45 min, followed by a 3 
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ml/min in 25 min. The temperature of the flame ionization detector was set at 300 °C. The oven 
temperature was programmed to hold at 90 °C for 2 minutes, then from 90 °C to 150 °C at 30 °C/min 
and then to 240 °C at 2.5 °C/min and held there for 30 minutes total analysis time was 70 min. Seventy 
well-defined peaks in the chromatogram were selected, and identified by comparing retention times 
with a FAME standard (GLC-463 from Nu-Chek Prep. Elysian, MN, USA) and retention index maps and 
mass spectral libraries (GC-MS) (http://www.chrombox.org/index.html)   performed under the same 
chromatographic conditions as the GC-FID (Mjos 2004). Chromatographic peak areas were corrected 
by empirical response factors calculated from the areas of the GLC-463 mixture. The chromatograms 
were integrated using the EZChrom Elite software (Agilent Technologies). Only those 42 FA that 
contribute with more that 0.1 % of the total fatty acids amount was used included in the data 
calculation. The total amount of fatty acids and cholesterol was calculated using the internal standard 
19:0, and the results is giving as mg FA/chol/100 mg wet weight sample. The fatty acids profile is 
precent FA relative to total FA. 
 
Statistics 
Statistical analyses of were performed using XLSTAT software (Addinsoft, US). One-way ANOVA and 
Dunnett’s post-hoc test were used to analyse statistical differences in most variables (except DNA adducts). 
The statistical analysis of the DNA adduct results presented in the report is based on the use of SAS® 
software by Mr. Didier Pottier, engineer biostatistician at the University of Caen (EA 4651 ABTE-TOXEMAC, 
France). Predictably, the DNA adduct levels measured in the overall samples, considered by condition, do 
not respect the classical Normal distribution, even after the logarithmic with base 10 transformation 
(Shapiro-Wilk test, results not shown). Therefore, the following statistical analyses are above all based on 
some nonparametric tests, Kruskal-Wallis Test. Parametric tests are used in order to complete (or 
reinforce) the statistical results. 
The Principle Component Analysis (PCA) of the FA profiles was carried out using Sirius (Version 8.1, Bergen, 
Norway). Before PCA the relative values (i.e. percent of the sum) were scaled by dividing each value by the 
mean of the values of all samples for that particular FA, with the intention to level out the quantitative 
difference among the FAs, leaving them all to vary around one. Score and loading plots from PCA analysis 
were generated in Sirius.  
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Table A1. PAH levels in PW, base oil (HDF200) and sediments form the North Sea
Concentration (µg/L ) (µg/kg) (µg/kg) (µg/kg) (µg/kg)
Number of rings Statfjord A (PW) HDF 200 oil Kaks (G-10) Kaks (G16) Sediment Skagerrak
Naphthalene 2 913 9627 3500 88 83
∑C1-Naphthalene 2 1689 51640 10100 410 187
∑C2-Naphthalene 2 470 214890 1230 621 252
∑C3-Naphthalene 2 104 360121 10200 950 210
Phenanthrene 3 58 1312 1580 146 184
∑C1-Phenantrene 3 82 1471 1740 349 248
∑C2-Phenantrene 3 15 195 3090 494 184
∑C3-Phenantrene 3 9 822 364 60
Dibenzothiofen 3 24 2251 299 31 17
C1-Dibenzothiophene 3 102 23970 838 199 20
C2-Dibenzothiophene 3 2.0 11532 1130 364 320
C3-Dibenzothiophene 3 1.5 418 341 42
Acenaphthylene 3 5.2 4453 49 20 9
Acenaphthene 3 4.2 58198 253 20 5.6
Anthracene 3 0.9 428 137 23 31
Fluoranthene 4 1.1 641 1040 77 238
Pyrene 4 1.4 16446 979 88 172
Benz(a)anthracene 4 0.6 297 905 23 161
Chrysene 4 2.9 242 652 31 193
Benzo(b)fluoranthene 5 0.4 0 0
Benzo(k)fluoranthene 5 0.4 745 20 1087
Benzo(e)pyrene 5 0.5 0 0 283
Benzo(a)pyrene 5 0.0 376 20 250
Perylene 5 0.0 0 0 90
Dibenz(a,h)anthracene 5 0.0 20 20 817
Indeno(1,2,3-cd)pyrene 6 0.0 20 20 982
Benzo(ghi)perylene 6 0.0 20 20 187
Sum 3487 757714 40143 4739 6313
Table A2. PAH levels in PW extract (Gullfaks) and destilation fraction of  Gullfaks oil used to make the experimental feed
mg/kg mg/kg mg/kg mg/kg mg/kg
PW ekstract Oil Fr1 (240-320 °C) Oil Fr2 (320-375 °C) Oil Fr3 (375-400 °C) Oil Fr4 (420-525 °C)
Naphthalene 13 115 7 0.8 0.1
∑C1-Naphthalene 409 6000 10 1.2 0.9
∑C2-Naphthalene 1974 25995 64 15 9.1
∑C3-Naphthalene 1653 24311 42 5.2 1.0
∑C4-Naphthalene 86 17 10 0.3 0.1
Phenanthrene 139 1168 520 0.7 0.1
∑C1-Phenantrene 396 469 4918 10.7 1.1
∑C2-Phenantrene 521 7 4538 37.5 1.0
∑C3-Phenantrene 555 0 6630 1115 121.9
∑C4-Phenantrene 4 0 9 65 9.9
Dibenzothiofen 6 103 39 0.0 0.0
C1-Dibenzothiophene 145 1285 3622 1.2 0.2
C2-Dibenzothiophene 287 88 4375 1.3 0.2
C3-Dibenzothiophene 353 2 4182 0.0 2.5
Acenaphthylene 36 22 0.3 0.0 0.0
Acenaphthene 13 6 0.2 0.0 0.0
Anthracene 7 48 48.8 2.5 0.5
Fluoranthene 4 0.0 75.1 1 0.0
Pyrene 5.1 0.2 92.3 6 0
Benz(a)anthracene 7.0 0.0 1.5 34 8
Chrysene 4.0 0.0 1.1 66 12
1-methylchrysene 3.7 0.1 0.2 54 24.4
6-ethylchrysene 1.4 0.1 0.1 15.3 0.0
6-propylcrysene 1.5 0.1 0.0 1 0
Benzo(b)fluoranthene 1.9 0.6 0.1 12 13
Benzo(k)fluoranthene 0.0 0.0 0.0 11 5.8
Benz(e)pyrene 8.9 0.0 0.0 86 0
Benzo(a)pyrene 1 0.2 0.1 10 11
Perylene 41.5 0.1 0.2 148.4 163
Dibenz(ah)anthracene 0.0 0.0 0.1 1.2 6
Indeno(1,2,3-cd)pyrene 0.0 0.3 0.3 2.0 11
Benzo(ghi)perylene 3 0 0 4 11
∑2 rings 4135 56439 133 23 11
∑3 rings 2462 3198.0 28883 1234 137
∑4 rings 27 0.4 170.3 178 44
∑5 rings 53.2 1.0 0.5 269 199
∑6 rings 2.63 0.33 0.39 6.52 22.22
Sum 6680 59639 29186 1710 414
% 0.67 5.96 2.92 0.17 0.04
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Table A3. PAH profile (%) in the PW, oil and PAH mixture used in the feed
PW mixture Oil mixture PAH mixture
Naphthalene 0.19 0.02 0
∑C1-Naphthalene 7.98 0.04 0
∑C2-Naphthalene 36.18 0.25 0
∑C3-Naphthalene 32.31 0.15 0
∑C4-Naphthalene 0.70 0.03 0
Phenanthrene 2.02 1.60 0
∑C1-Phenantrene 3.50 15.14 0
∑C2-Phenantrene 4.13 14.07 0
∑C3-Phenantrene 4.39 24.47 0
∑C4-Phenantrene 0.03 0.27 0
Dibenzothiofen 0.13 0.12 0
C1-Dibenzothiophene 2.16 11.12 0
C2-Dibenzothiophene 2.34 13.44 0
C3-Dibenzothiophene 2.79 12.84 0
Acenaphthylene 0.30 0.00 0
Acenaphthene 0.10 0.00 0
Anthracene 0.09 0.16 0
Fluoranthene 0.00 0.00 5
Pyrene 0.03 4.33 4
Benz(a)anthracene 0.04 0.31 3
Chrysene 0.06 0.13 4
1-methylchrysene 0.03 0.25 0
6-ethylchrysene 0.03 0.20 0
6-propylcrysene 0.01 0.06 0
Benzo(b)fluoranthene 0.01 0.01 13
Benzo(k)fluoranthene 0.02 0.04 12
Benz(e)pyrene 0.00 0.04 5
Benzo(a)pyrene 0.07 0.32 6
Perylene 0.01 0.04 2
Dibenz(ah)anthracene 0.33 0.55 19
Indeno(1,2,3-cd)pyrene 0.00 0.01 22
Benzo(ghi)perylene 0.00 0.01 4
∑2 rings 77.36 0.49 0
∑3 rings 22.01 93.23 0
∑4 rings 0.20 5.27 17
∑5 rings 0.43 1.00 57
∑6 rings 0.00 0.01 26
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Table A4. Fatty acid profile in haddock liver from the different treatments groups after two one month 
exposure. FA that represents less than 0.1 % of the total FAs are removed from the table, but is 
included in the total sum of FAs. The total amounts of FAs relatively too wet weight is giving in bottom 
of table. Data presented as average + stdev. Bold numbers indicate significant differences compared 
with control, p< 0.05. 
Control (22/4) PW (22/4) Oil (22/4) PAH (22/4)
(n=10) (n=10) (n=10) (n=10)
 14:0 3.80 ± 0.23 3.76 ± 0.25 3.68 ± 0.14 3.76 ± 0.25
Iso 15:0 0.14 ± 0.01 0.14 ± 0.01 0.14 ± 0.01 0.14 ± 0.01
 15:0 0.32 ± 0.01 0.32 ± 0.02 0.31 ± 0.02 0.33 ± 0.02
 16:0 17.58 ± 1.82 18.68 ± 1.26 18.66 ± 0.42 18.05 ± 0.76
Iso 17:0 0.259 ± 0.013 0.252 ± 0.011 0.248 ± 0.004 0.234 ± 0.024
Antiso 17:0 0.10 ± 0.01 0.10 ± 0.01 0.09 ± 0.01 0.11 ± 0.01
 17:0 0.20 ± 0.03 0.19 ± 0.02 0.20 ± 0.01 0.22 ± 0.02
 18:0 3.35 ± 0.53 3.50 ± 0.57 4.07 ± 0.62 3.88 ± 0.72
 20:0 0.128 ± 0.008 0.126 ± 0.006 0.124 ± 0.006 0.119 ± 0.003
∑SFA 26.12 ± 1.82 27.29 ± 1.28 27.78 ± 0.35 27.15 ± 0.78
16:1 (n-11) 0.20 ± 0.04 0.17 ± 0.03 0.17 ± 0.02 0.21 ± 0.03
16:1 (n-9) 0.301 ± 0.021 0.294 ± 0.013 0.307 ± 0.004 0.337 ± 0.022
16:1 (n-7) 5.74 ± 0.48 5.87 ± 0.41 5.63 ± 0.13 5.74 ± 0.38
16:1 (n-5) 0.16 ± 0.01 0.16 ± 0.02 0.16 ± 0.01 0.16 ± 0.02
∑17:1 0.49 ± 0.03 0.49 ± 0.03 0.48 ± 0.01 0.51 ± 0.03
18:1 (n-11) 0.50 ± 0.12 0.40 ± 0.08 0.35 ± 0.04 0.44 ± 0.15
18:1 (n-9) 19.45 ± 1.13 19.88 ± 1.17 20.16 ± 1.31 20.46 ± 1.50
18:1 (n-7) 3.53 ± 0.21 3.48 ± 0.13 3.44 ± 0.15 3.73 ± 0.22
18:1 (n-5) 0.36 ± 0.02 0.35 ± 0.02 0.35 ± 0.01 0.36 ± 0.02
20:1 (n-11) 1.09 ± 0.12 1.08 ± 0.10 1.05 ± 0.04 1.08 ± 0.10
20:1 (n-9) 6.17 ± 0.40 5.82 ± 0.53 5.82 ± 0.44 5.87 ± 0.62
20:1 (n-7) 0.21 ± 0.01 0.20 ± 0.01 0.20 ± 0.01 0.20 ± 0.01
22:1 (n-11) 7.44 ± 0.78 7.04 ± 0.51 6.79 ± 0.61 6.29 ± 0.93
22:1 (n-9) 0.58 ± 0.04 0.56 ± 0.03 0.55 ± 0.05 0.52 ± 0.06
22:1 (n-7) 0.09 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 0.07 ± 0.01
24:1 (n-9) 0.66 ± 0.04 0.63 ± 0.03 0.60 ± 0.03 0.56 ± 0.03
24:1 (n-7) 0.110 ± 0.005 0.101 ± 0.007 0.101 ± 0.006 0.068 ± 0.021
∑MUFA 47.13 ± 0.95 46.67 ± 0.75 46.28 ± 0.99 46.67 ± 1.04
16:4 (n-1) 0.350 ± 0.042 0.360 ± 0.033 0.362 ± 0.018 0.348 ± 0.026
18:4 (n-1) 0.144 ± 0.013 0.139 ± 0.013 0.137 ± 0.006 0.140 ± 0.009
16:2 (n-4) 0.33 ± 0.03 0.32 ± 0.03 0.33 ± 0.01 0.34 ± 0.02
16:3 (n-4) 0.284 ± 0.042 0.284 ± 0.028 0.289 ± 0.005 0.298 ± 0.031
18:2 (n-4) 0.21 ± 0.03 0.21 ± 0.02 0.20 ± 0.01 0.23 ± 0.02
18:2 (n-6) 3.88 ± 0.28 3.79 ± 0.28 3.85 ± 0.12 3.92 ± 0.33
18:3 (n-6) 0.11 ± 0.02 0.11 ± 0.03 0.12 ± 0.03 0.10 ± 0.02
20:2 (n-6) 0.30 ± 0.02 0.28 ± 0.02 0.28 ± 0.01 0.29 ± 0.02
20:3 (n-6) 0.065 ± 0.008 0.062 ± 0.004 0.063 ± 0.003 0.068 ± 0.005
20:4 (n-6) 0.41 ± 0.02 0.40 ± 0.02 0.39 ± 0.01 0.40 ± 0.04
22:4 (n-6) 0.14 ± 0.02 0.12 ± 0.01 0.12 ± 0.01 0.13 ± 0.02
22:5 (n-6) 0.14 ± 0.02 0.13 ± 0.01 0.13 ± 0.02 0.13 ± 0.02
18:3 (n-3) 1.03 ± 0.08 1.00 ± 0.07 1.01 ± 0.01 1.08 ± 0.04
18:4 (n-3) 1.77 ± 0.12 1.74 ± 0.14 1.77 ± 0.08 1.76 ± 0.07
20:3  (n-3) 0.118 ± 0.007 0.112 ± 0.005 0.114 ± 0.002 0.107 ± 0.009
20:4 (n-3) 0.512 ± 0.042 0.487 ± 0.031 0.495 ± 0.003 0.480 ± 0.040
20:5 (n-3) 6.60 ± 0.50 6.47 ± 0.36 6.39 ± 0.18 6.60 ± 0.35
21:5 (n-3) 0.31 ± 0.03 0.29 ± 0.02 0.28 ± 0.02 0.29 ± 0.02
22:5 (n-3) 1.12 ± 0.10 1.06 ± 0.07 1.06 ± 0.03 1.07 ± 0.10
22:6 (n-3) 8.39 ± 0.42 8.17 ± 0.31 8.05 ± 0.44 7.91 ± 0.31
24:5 (n-3) 0.26 ± 0.02 0.24 ± 0.02 0.24 ± 0.02 0.22 ± 0.02
∑PUFA 26.75 ± 1.76 26.04 ± 1.32 25.94 ± 0.72 26.19 ± 1.02
∑(n-6) PUFA 5.09 ± 0.37 4.94 ± 0.32 4.99 ± 0.10 5.10 ± 0.34
∑(n-3) PUFA 20.19 ± 1.27 19.63 ± 0.92 19.46 ± 0.68 19.58 ± 0.73
(n-3)/(n-6) 3.97 ± 0.07 3.98 ± 0.11 3.90 ± 0.13 3.85 ± 0.26
Amount of Cholesterol (%) 0.15 ± 0.02 0.15 ± 0.01 0.16 ± 0.02 0.19 ± 0.04
Amount of FA (%) 52.79 ± 3.04 56.07 ± 2.79 53.93 ± 2.30 48.70 ± 7.05  
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Table A5. Fatty acid profile in haddock liver from the different treatments groups after one week 
recovery. FA that represents less than 0.1 % of the total FAs are removed from the table, but is 
included in the total sum of FAs. Data presented as average ± stdev. Bold numbers indicate significant 
differences compared with control, p< 0.05. 
Control (29/4) PW (29/4) Oil (29/4) PAH (29/4)
(n=10) (n=10) (n=10) (n=10)
 14:0 4.03 ± 0.23 3.91 ± 0.14 3.74 ± 0.22 3.48 ± 0.20
Iso 15:0 0.15 ± 0.01 0.14 ± 0.01 0.14 ± 0.01 0.14 ± 0.01
 15:0 0.34 ± 0.02 0.32 ± 0.02 0.31 ± 0.02 0.31 ± 0.01
 16:0 18.39 ± 1.43 17.75 ± 1.53 17.78 ± 1.06 16.25 ± 1.41
Iso 17:0 0.23 ± 0.01 0.21 ± 0.01 0.19 ± 0.02 0.17 ± 0.01
Antiso 17:0 0.111 ± 0.004 0.108 ± 0.006 0.109 ± 0.003 0.111 ± 0.004
 17:0 0.21 ± 0.03 0.21 ± 0.03 0.21 ± 0.02 0.25 ± 0.03
 18:0 3.61 ± 0.82 3.25 ± 0.59 3.49 ± 0.41 4.26 ± 0.76
 20:0 0.122 ± 0.008 0.106 ± 0.004 0.108 ± 0.006 0.121 ± 0.016
∑SFA 27.53 ± 1.50 26.43 ± 1.44 26.47 ± 1.04 25.46 ± 1.57
16:1 (n-11) 0.20 ± 0.03 0.18 ± 0.04 0.18 ± 0.02 0.21 ± 0.04
16:1 (n-9) 0.32 ± 0.02 0.29 ± 0.03 0.30 ± 0.02 0.32 ± 0.03
16:1 (n-7) 5.86 ± 0.47 5.82 ± 0.44 5.73 ± 0.29 5.35 ± 0.36
16:1 (n-5) 0.17 ± 0.02 0.17 ± 0.01 0.17 ± 0.01 0.16 ± 0.01
∑17:1 0.51 ± 0.04 0.46 ± 0.03 0.49 ± 0.03 0.51 ± 0.03
18:1 (n-11) 0.54 ± 0.07 0.28 ± 0.04 0.33 ± 0.09 0.40 ± 0.08
18:1 (n-9) 19.77 ± 0.72 19.18 ± 0.81 19.84 ± 1.28 20.08 ± 1.21
18:1 (n-7) 3.57 ± 0.14 3.52 ± 0.14 3.57 ± 0.21 3.75 ± 0.16
18:1 (n-5) 0.36 ± 0.01 0.35 ± 0.01 0.36 ± 0.01 0.34 ± 0.02
20:1 (n-11) 1.11 ± 0.07 0.90 ± 0.08 0.86 ± 0.11 0.89 ± 0.10
20:1 (n-9) 6.22 ± 0.38 6.42 ± 0.41 6.27 ± 0.19 5.79 ± 0.63
20:1 (n-7) 0.20 ± 0.01 0.22 ± 0.01 0.21 ± 0.01 0.22 ± 0.01
22:1 (n-11) 6.95 ± 0.64 7.47 ± 0.82 7.04 ± 0.47 6.11 ± 0.90
22:1 (n-9) 0.56 ± 0.03 0.58 ± 0.04 0.56 ± 0.03 0.53 ± 0.05
22:1 (n-7) 0.08 ± 0.01 0.08 ± 0.00 0.08 ± 0.00 0.04 ± 0.02
24:1 (n-9) 0.59 ± 0.04 0.70 ± 0.04 0.67 ± 0.06 0.66 ± 0.06
24:1 (n-7) 0.053 ± 0.012 0.074 ± 0.004 0.065 ± 0.007 0.092 ± 0.039
∑MUFA 47.11 ± 0.67 46.77 ± 1.01 46.78 ± 1.31 45.49 ± 1.79
16:4 (n-1) 0.33 ± 0.04 0.34 ± 0.04 0.32 ± 0.04 0.36 ± 0.05
18:4 (n-1) 0.13 ± 0.01 0.15 ± 0.02 0.14 ± 0.01 0.16 ± 0.01
16:2 (n-4) 0.33 ± 0.03 0.32 ± 0.05 0.32 ± 0.03 0.35 ± 0.03
16:3 (n-4) 0.28 ± 0.04 0.28 ± 0.05 0.27 ± 0.04 0.32 ± 0.05
18:2 (n-4) 0.21 ± 0.02 0.21 ± 0.03 0.21 ± 0.02 0.25 ± 0.03
18:2 (n-6) 3.88 ± 0.28 3.91 ± 0.37 3.93 ± 0.25 4.17 ± 0.23
18:3 (n-6) 0.09 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.11 ± 0.01
20:2 (n-6) 0.29 ± 0.02 0.29 ± 0.02 0.30 ± 0.01 0.31 ± 0.02
20:3 (n-6) 0.065 ± 0.008 0.070 ± 0.010 0.071 ± 0.005 0.081 ± 0.008
20:4 (n-6) 0.37 ± 0.03 0.41 ± 0.04 0.41 ± 0.02 0.45 ± 0.06
22:4 (n-6) 0.12 ± 0.03 0.13 ± 0.02 0.12 ± 0.01 0.12 ± 0.02
22:5 (n-6) 0.12 ± 0.02 0.14 ± 0.02 0.15 ± 0.01 0.17 ± 0.02
18:3 (n-3) 1.07 ± 0.09 1.10 ± 0.13 1.07 ± 0.07 1.15 ± 0.09
18:4 (n-3) 1.75 ± 0.12 1.84 ± 0.14 1.79 ± 0.12 1.83 ± 0.13
20:3  (n-3) 0.10 ± 0.01 0.11 ± 0.01 0.11 ± 0.01 0.11 ± 0.01
20:4 (n-3) 0.49 ± 0.04 0.54 ± 0.06 0.52 ± 0.03 0.56 ± 0.05
20:5 (n-3) 6.32 ± 0.42 6.75 ± 0.75 6.72 ± 0.35 7.52 ± 0.65
21:5 (n-3) 0.28 ± 0.03 0.31 ± 0.04 0.30 ± 0.02 0.34 ± 0.04
22:5 (n-3) 1.00 ± 0.09 1.09 ± 0.13 1.12 ± 0.08 1.30 ± 0.18
22:6 (n-3) 7.67 ± 0.31 8.29 ± 0.29 8.36 ± 0.33 8.94 ± 0.69
24:5 (n-3) 0.22 ± 0.02 0.21 ± 0.02 0.22 ± 0.01 0.20 ± 0.02
∑PUFA 25.37 ± 1.49 26.80 ± 2.13 26.75 ± 1.37 29.05 ± 2.14
∑(n-6) PUFA 4.98 ± 0.36 5.09 ± 0.48 5.12 ± 0.31 5.47 ± 0.32
∑(n-3) PUFA 18.95 ± 1.01 20.28 ± 1.48 20.24 ± 0.95 21.99 ± 1.68
(n-3)/(n-6) 3.81 ± 0.10 3.99 ± 0.13 3.96 ± 0.09 4.02 ± 0.12
Amount of Cholesterol (%) 0.17 ± 0.02 0.16 ± 0.01 0.17 ± 0.01 0.24 ± 0.20
Amount of FA (%) 51.85 ± 4.72 56.38 ± 3.64 58.53 ± 2.66 54.96 ± 7.73  
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Table A6. Fatty acid profile in haddock liver from the different treatments groups after two months of 
recovery. FA that represents less than 0.1 % of the total FAs are removed from the table, but is 
included in the total sum of FAs. Data presented as average ± stdev. Bold numbers indicate significant 
differences compared with control, p< 0.05. 
Control (19/6) PW (19/6) Oil (19/6) PAH (19/6)
(n=10) (n=10) (n=9) (n=10)
 14:0 3.90 ± 0.22 3.91 ± 0.37 3.59 ± 0.23 3.46 ± 0.15
Iso 15:0 0.14 ± 0.01 0.15 ± 0.01 0.13 ± 0.01 0.14 ± 0.01
 15:0 0.31 ± 0.01 0.32 ± 0.02 0.30 ± 0.01 0.30 ± 0.01
 16:0 17.97 ± 1.20 17.29 ± 1.33 17.83 ± 0.89 16.69 ± 1.27
Iso 17:0 0.19 ± 0.01 0.22 ± 0.01 0.22 ± 0.01 0.23 ± 0.01
Antiso 17:0 0.108 ± 0.004 0.109 ± 0.004 0.107 ± 0.005 0.110 ± 0.005
 17:0 0.19 ± 0.02 0.20 ± 0.03 0.20 ± 0.02 0.23 ± 0.03
 18:0 3.28 ± 0.51 3.25 ± 0.51 3.71 ± 0.43 4.00 ± 0.42
 20:0 0.096 ± 0.007 0.101 ± 0.006 0.100 ± 0.005 0.104 ± 0.005
∑SFA 26.46 ± 1.13 25.87 ± 1.39 26.49 ± 0.89 25.58 ± 1.21
16:1 (n-11) 0.19 ± 0.01 0.20 ± 0.03 0.18 ± 0.03 0.21 ± 0.05
16:1 (n-9) 0.30 ± 0.02 0.31 ± 0.04 0.30 ± 0.02 0.32 ± 0.03
16:1 (n-7) 5.77 ± 0.42 5.63 ± 0.49 5.52 ± 0.26 5.41 ± 0.31
16:1 (n-5) 0.17 ± 0.01 0.17 ± 0.02 0.16 ± 0.01 0.16 ± 0.01
∑17:1 0.49 ± 0.02 0.49 ± 0.02 0.50 ± 0.02 0.51 ± 0.02
18:1 (n-11) 0.65 ± 0.13 0.79 ± 0.13 0.77 ± 0.17 0.86 ± 0.20
18:1 (n-9) 19.63 ± 1.52 18.78 ± 1.93 20.74 ± 0.91 20.70 ± 1.10
18:1 (n-7) 3.55 ± 0.23 3.51 ± 0.33 3.65 ± 0.15 3.76 ± 0.21
18:1 (n-5) 0.37 ± 0.02 0.37 ± 0.03 0.37 ± 0.02 0.36 ± 0.03
20:1 (n-11) 0.98 ± 0.09 1.02 ± 0.06 0.99 ± 0.06 0.96 ± 0.14
20:1 (n-9) 6.62 ± 0.47 6.87 ± 0.71 6.55 ± 0.34 6.60 ± 0.52
20:1 (n-7) 0.21 ± 0.01 0.21 ± 0.01 0.20 ± 0.02 0.21 ± 0.01
22:1 (n-11) 7.74 ± 0.94 7.81 ± 1.53 7.18 ± 0.45 6.74 ± 0.79
22:1 (n-9) 0.61 ± 0.06 0.62 ± 0.08 0.58 ± 0.03 0.55 ± 0.05
22:1 (n-7) 0.08 ± 0.01 0.09 ± 0.01 0.08 ± 0.01 0.08 ± 0.01
24:1 (n-9) 0.70 ± 0.06 0.70 ± 0.07 0.64 ± 0.05 0.64 ± 0.04
24:1 (n-7) 0.06 ± 0.02 0.06 ± 0.01 0.06 ± 0.01 0.07 ± 0.01
∑MUFA 48.18 ± 0.74 47.71 ± 0.75 48.54 ± 0.73 48.20 ± 0.82
16:4 (n-1) 0.29 ± 0.03 0.29 ± 0.04 0.28 ± 0.03 0.30 ± 0.03
18:4 (n-1) 0.13 ± 0.01 0.14 ± 0.01 0.13 ± 0.01 0.14 ± 0.01
16:2 (n-4) 0.29 ± 0.03 0.30 ± 0.02 0.29 ± 0.02 0.31 ± 0.03
16:3 (n-4) 0.23 ± 0.03 0.24 ± 0.04 0.23 ± 0.02 0.27 ± 0.04
18:2 (n-4) 0.19 ± 0.02 0.19 ± 0.03 0.19 ± 0.02 0.21 ± 0.02
18:2 (n-6) 3.76 ± 0.20 3.93 ± 0.19 3.77 ± 0.14 4.01 ± 0.21
18:3 (n-6) 0.087 ± 0.007 0.089 ± 0.006 0.085 ± 0.003 0.090 ± 0.006
20:2 (n-6) 0.28 ± 0.02 0.30 ± 0.02 0.29 ± 0.01 0.30 ± 0.02
20:3 (n-6) 0.065 ± 0.007 0.066 ± 0.008 0.063 ± 0.004 0.069 ± 0.006
20:4 (n-6) 0.37 ± 0.01 0.38 ± 0.04 0.36 ± 0.02 0.39 ± 0.03
22:4 (n-6) 0.13 ± 0.01 0.12 ± 0.01 0.11 ± 0.01 0.11 ± 0.01
22:5 (n-6) 0.12 ± 0.01 0.13 ± 0.02 0.12 ± 0.01 0.13 ± 0.01
18:3 (n-3) 1.05 ± 0.07 1.09 ± 0.06 1.04 ± 0.04 1.11 ± 0.06
18:4 (n-3) 1.77 ± 0.13 1.83 ± 0.11 1.74 ± 0.07 1.80 ± 0.08
20:3  (n-3) 0.10 ± 0.01 0.11 ± 0.01 0.10 ± 0.01 0.11 ± 0.01
20:4 (n-3) 0.50 ± 0.03 0.53 ± 0.03 0.50 ± 0.02 0.52 ± 0.03
20:5 (n-3) 6.18 ± 0.33 6.45 ± 0.54 6.09 ± 0.18 6.49 ± 0.43
21:5 (n-3) 0.28 ± 0.02 0.30 ± 0.03 0.27 ± 0.02 0.29 ± 0.02
22:5 (n-3) 0.94 ± 0.07 0.99 ± 0.13 0.93 ± 0.06 0.99 ± 0.09
22:6 (n-3) 8.16 ± 0.26 8.51 ± 0.41 7.97 ± 0.28 8.17 ± 0.45
24:5 (n-3) 0.21 ± 0.02 0.22 ± 0.03 0.19 ± 0.02 0.20 ± 0.02
∑PUFA 25.36 ± 1.15 26.42 ± 1.54 24.97 ± 0.79 26.22 ± 1.37
∑(n-6) PUFA 4.85 ± 0.25 5.06 ± 0.26 4.85 ± 0.16 5.15 ± 0.29
∑(n-3) PUFA 19.24 ± 0.82 20.08 ± 1.19 18.87 ± 0.60 19.72 ± 1.03
(n-3)/(n-6) 3.97 ± 0.09 3.97 ± 0.10 3.89 ± 0.06 3.83 ± 0.11
Amount of Cholesterol (%) 0.16 ± 0.02 0.15 ± 0.03 0.14 ± 0.03 0.15 ± 0.02
Amount of FA (%) 60.45 ± 3.24 59.05 ± 8.98 58.36 ± 6.94 58.88 ± 4.15  
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Table A7. Fatty acid profile in haddock muscle from the different treatments groups after two months 
ofexposure. FA that represents less than 0.1 % of the total FAs are removed from the table, but is 
included in the total sum of FAs. Data presented as average ± stdev. Bold numbers indicate significant 
differences compared with control, p< 0.05. 
Muscle Control (22/4) PW (22/4) Oil (22/4) PAH (22/4)
(n=10) (n=10) (n=10) (n=9)
 14:0 2.44 ± 0.43 2.56 ± 0.12 2.30 ± 0.25 1.97 ± 0.31
Iso 15:0 0.09 ± 0.02 0.09 ± 0.01 0.09 ± 0.01 0.07 ± 0.01
 15:0 0.34 ± 0.03 0.34 ± 0.01 0.33 ± 0.02 0.31 ± 0.03
 16:0 17.31 ± 0.75 17.50 ± 0.78 17.44 ± 0.57 17.48 ± 0.48
Iso 17:0 0.16 ± 0.01 0.16 ± 0.00 0.16 ± 0.01 0.14 ± 0.03
Antiso 17:0 0.08 ± 0.01 0.08 ± 0.01 0.08 ± 0.02 0.07 ± 0.01
 17:0 0.20 ± 0.01 0.20 ± 0.01 0.21 ± 0.03 0.20 ± 0.01
 18:0 2.99 ± 0.39 2.94 ± 0.20 3.34 ± 0.43 3.29 ± 0.38
 20:0 0.046 ± 0.007 0.048 ± 0.006 0.045 ± 0.011 0.037 ± 0.005
∑SFA 24.05 ± 0.72 24.34 ± 0.90 24.43 ± 0.97 24.00 ± 0.57
16:1 (n-11) 0.18 ± 0.03 0.17 ± 0.02 0.17 ± 0.01 0.16 ± 0.03
16:1 (n-9) 0.32 ± 0.04 0.32 ± 0.02 0.34 ± 0.04 0.31 ± 0.04
16:1 (n-7) 2.35 ± 0.41 2.51 ± 0.14 2.27 ± 0.32 1.94 ± 0.31
16:1 (n-5) 0.25 ± 0.02 0.25 ± 0.01 0.25 ± 0.01 0.23 ± 0.02
∑17:1 0.40 ± 0.04 0.42 ± 0.01 0.42 ± 0.04 0.38 ± 0.05
18:1 (n-11) 1.13 ± 0.33 0.87 ± 0.26 1.05 ± 0.17 1.02 ± 0.22
18:1 (n-9) 9.13 ± 0.73 10.02 ± 0.71 9.61 ± 1.13 8.85 ± 0.63
18:1 (n-7) 2.33 ± 0.10 2.38 ± 0.12 2.37 ± 0.10 2.32 ± 0.08
18:1 (n-5) 0.31 ± 0.03 0.31 ± 0.02 0.30 ± 0.01 0.28 ± 0.03
20:1 (n-11) 0.45 ± 0.06 0.46 ± 0.09 0.42 ± 0.04 0.39 ± 0.06
20:1 (n-9) 2.79 ± 0.37 2.90 ± 0.28 2.62 ± 0.28 2.30 ± 0.43
20:1 (n-7) 0.07 ± 0.02 0.08 ± 0.01 0.07 ± 0.02 0.06 ± 0.01
22:1 (n-11) 1.93 ± 0.37 2.06 ± 0.40 1.70 ± 0.27 1.35 ± 0.36
22:1 (n-9) 0.20 ± 0.03 0.23 ± 0.04 0.21 ± 0.01 0.18 ± 0.03
22:1 (n-7) 0.05 ± 0.01 0.06 ± 0.00 0.06 ± 0.00 0.04 ± 0.01
24:1 (n-9) 1.01 ± 0.08 1.11 ± 0.15 1.04 ± 0.04 0.99 ± 0.08
24:1 (n-7) 0.15 ± 0.06 0.14 ± 0.02 0.15 ± 0.03 0.18 ± 0.04
∑MUFA 23.09 ± 2.07 24.29 ± 1.36 23.07 ± 1.86 20.99 ± 2.17
16:4 (n-1) 0.041 ± 0.021 0.062 ± 0.029 0.052 ± 0.018 0.031 ± 0.007
18:4 (n-1) 0.09 ± 0.01 0.10 ± 0.01 0.09 ± 0.01 0.08 ± 0.01
16:2 (n-4) 0.14 ± 0.02 0.15 ± 0.01 0.13 ± 0.02 0.11 ± 0.02
16:3 (n-4) 0.05 ± 0.01 0.06 ± 0.01 0.05 ± 0.01 0.04 ± 0.01
18:2 (n-4) 0.13 ± 0.01 0.13 ± 0.01 0.12 ± 0.02 0.12 ± 0.01
18:2 (n-6) 3.51 ± 0.32 3.62 ± 0.11 3.57 ± 0.18 3.53 ± 0.25
18:3 (n-6) 0.06 ± 0.02 0.06 ± 0.01 0.06 ± 0.01 0.06 ± 0.01
20:2 (n-6) 0.35 ± 0.04 0.37 ± 0.03 0.38 ± 0.09 0.34 ± 0.03
20:3 (n-6) 0.102 ± 0.006 0.101 ± 0.006 0.100 ± 0.006 0.110 ± 0.006
20:4 (n-6) 1.16 ± 0.10 1.14 ± 0.08 1.19 ± 0.08 1.29 ± 0.13
22:4 (n-6) 0.16 ± 0.02 0.18 ± 0.02 0.16 ± 0.01 0.17 ± 0.01
22:5 (n-6) 0.48 ± 0.03 0.47 ± 0.02 0.48 ± 0.03 0.52 ± 0.04
18:3 (n-3) 0.75 ± 0.08 0.79 ± 0.03 0.73 ± 0.06 0.67 ± 0.08
18:4 (n-3) 1.00 ± 0.10 1.06 ± 0.04 0.98 ± 0.10 0.87 ± 0.10
20:3  (n-3) 0.10 ± 0.01 0.11 ± 0.01 0.11 ± 0.03 0.10 ± 0.01
20:4 (n-3) 0.65 ± 0.07 0.64 ± 0.03 0.66 ± 0.05 0.65 ± 0.05
20:5 (n-3) 14.23 ± 0.48 13.82 ± 0.68 14.04 ± 0.96 15.11 ± 0.79
21:5 (n-3) 0.29 ± 0.02 0.30 ± 0.01 0.29 ± 0.02 0.29 ± 0.02
22:5 (n-3) 1.68 ± 0.06 1.67 ± 0.07 1.73 ± 0.09 1.75 ± 0.06
22:6 (n-3) 27.38 ± 1.61 26.09 ± 1.10 27.11 ± 2.28 28.72 ± 1.73
24:5 (n-3) 0.27 ± 0.04 0.27 ± 0.06 0.25 ± 0.03 0.25 ± 0.03
∑PUFA 52.85 ± 1.83 51.38 ± 1.71 52.50 ± 2.68 55.01 ± 1.96
∑(n-6) PUFA 5.90 ± 0.35 6.00 ± 0.17 6.00 ± 0.19 6.09 ± 0.19
∑(n-3) PUFA 46.44 ± 1.75 44.83 ± 1.67 45.98 ± 2.71 48.48 ± 2.03
(n-3)/(n-6) 7.89 ± 0.48 7.47 ± 0.27 7.67 ± 0.49 7.97 ± 0.46
Amount of Cholesterol (%) 0.06 ± 0.01 0.06 ± 0.02 0.07 ± 0.01 0.06 ± 0.00
Amount of FA (%) 0.74 ± 0.06 0.76 ± 0.06 0.76 ± 0.05 0.73 ± 0.02  
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Table A8. Fatty acid profile in haddock muscle from the different treatments groups after one week 
recovery. FA that represents less than 0.1 % of the total FAs are removed from the table, but is 
included in the total sum of FAs. Data presented as average ± stdev. Bold numbers indicate significant 
differences compared with control, p< 0.05. 
29/4 29/4 29/4 29/4
Muscle Control (29/4) PW (29/4) Oil (29/4) PAH (29/4)
(n=10) (n=10) (n=10) (n=9)
 14:0 2.22 ± 0.47 2.50 ± 0.48 2.17 ± 0.47 1.69 ± 0.53
Iso 15:0 0.08 ± 0.02 0.09 ± 0.02 0.08 ± 0.02 0.06 ± 0.02
 15:0 0.33 ± 0.03 0.34 ± 0.03 0.32 ± 0.03 0.28 ± 0.05
 16:0 17.78 ± 0.88 17.46 ± 0.78 17.42 ± 0.89 17.42 ± 0.69
Iso 17:0 0.12 ± 0.01 0.13 ± 0.01 0.12 ± 0.01 0.12 ± 0.01
Antiso 17:0 0.08 ± 0.01 0.08 ± 0.01 0.08 ± 0.01 0.08 ± 0.01
 17:0 0.20 ± 0.01 0.20 ± 0.02 0.20 ± 0.01 0.20 ± 0.01
 18:0 3.08 ± 0.52 2.98 ± 0.33 3.05 ± 0.36 3.51 ± 0.68
 20:0 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.01
∑SFA 24.38 ± 0.81 24.30 ± 0.69 23.93 ± 0.84 23.91 ± 0.79
16:1 (n-11) 0.16 ± 0.03 0.18 ± 0.04 0.16 ± 0.03 0.15 ± 0.02
16:1 (n-9) 0.32 ± 0.04 0.34 ± 0.06 0.32 ± 0.06 0.28 ± 0.05
16:1 (n-7) 2.16 ± 0.36 2.36 ± 0.50 2.24 ± 0.48 1.66 ± 0.43
16:1 (n-5) 0.26 ± 0.03 0.27 ± 0.02 0.25 ± 0.03 0.21 ± 0.03
∑17:1 0.41 ± 0.04 0.43 ± 0.05 0.44 ± 0.04 0.41 ± 0.05
18:1 (n-11) 1.07 ± 0.26 1.19 ± 0.32 1.05 ± 0.28 0.97 ± 0.20
18:1 (n-9) 9.11 ± 0.84 9.15 ± 1.22 9.35 ± 1.01 8.26 ± 0.97
18:1 (n-7) 2.32 ± 0.07 2.34 ± 0.10 2.36 ± 0.13 2.29 ± 0.10
18:1 (n-5) 0.31 ± 0.03 0.31 ± 0.03 0.30 ± 0.03 0.25 ± 0.03
20:1 (n-11) 0.44 ± 0.06 0.51 ± 0.10 0.43 ± 0.07 0.37 ± 0.06
20:1 (n-9) 2.41 ± 0.36 2.79 ± 0.56 2.54 ± 0.51 2.09 ± 0.34
20:1 (n-7) 0.06 ± 0.01 0.07 ± 0.02 0.07 ± 0.02 0.06 ± 0.01
22:1 (n-11) 1.58 ± 0.30 1.80 ± 0.46 1.79 ± 0.77 1.39 ± 0.37
22:1 (n-9) 0.19 ± 0.02 0.21 ± 0.04 0.22 ± 0.07 0.20 ± 0.05
22:1 (n-7) 0.04 ± 0.00 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.01
24:1 (n-9) 1.00 ± 0.09 1.01 ± 0.05 1.09 ± 0.22 1.18 ± 0.29
24:1 (n-7) 0.15 ± 0.05 0.17 ± 0.04 0.19 ± 0.04 0.15 ± 0.05
∑MUFA 22.01 ± 1.96 23.18 ± 2.94 22.86 ± 2.93 19.97 ± 2.38
16:4 (n-1) 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.02 0.03 ± 0.01
18:4 (n-1) 0.09 ± 0.01 0.09 ± 0.01 0.09 ± 0.02 0.07 ± 0.02
16:2 (n-4) 0.12 ± 0.03 0.14 ± 0.03 0.13 ± 0.04 0.09 ± 0.03
16:3 (n-4) 0.04 ± 0.01 0.05 ± 0.02 0.05 ± 0.02 0.03 ± 0.01
18:2 (n-4) 0.13 ± 0.01 0.12 ± 0.01 0.12 ± 0.01 0.12 ± 0.01
18:2 (n-6) 3.57 ± 0.22 3.59 ± 0.21 3.60 ± 0.24 3.30 ± 0.31
18:3 (n-6) 0.06 ± 0.02 0.06 ± 0.02 0.05 ± 0.01 0.06 ± 0.02
20:2 (n-6) 0.35 ± 0.06 0.37 ± 0.05 0.35 ± 0.04 0.31 ± 0.05
20:3 (n-6) 0.10 ± 0.01 0.10 ± 0.01 0.11 ± 0.01 0.11 ± 0.01
20:4 (n-6) 1.17 ± 0.12 1.13 ± 0.14 1.20 ± 0.10 1.45 ± 0.19
22:4 (n-6) 0.17 ± 0.02 0.18 ± 0.02 0.17 ± 0.02 0.16 ± 0.03
22:5 (n-6) 0.48 ± 0.03 0.47 ± 0.05 0.48 ± 0.04 0.53 ± 0.05
18:3 (n-3) 0.70 ± 0.07 0.71 ± 0.09 0.70 ± 0.11 0.58 ± 0.12
18:4 (n-3) 0.95 ± 0.12 1.00 ± 0.16 0.97 ± 0.17 0.79 ± 0.19
20:3  (n-3) 0.10 ± 0.02 0.11 ± 0.01 0.10 ± 0.01 0.09 ± 0.02
20:4 (n-3) 0.65 ± 0.07 0.66 ± 0.06 0.66 ± 0.05 0.61 ± 0.09
20:5 (n-3) 14.46 ± 0.46 13.90 ± 0.73 14.56 ± 0.77 15.37 ± 0.68
21:5 (n-3) 0.29 ± 0.02 0.29 ± 0.02 0.29 ± 0.02 0.27 ± 0.03
22:5 (n-3) 1.69 ± 0.06 1.67 ± 0.10 1.70 ± 0.06 1.71 ± 0.07
22:6 (n-3) 28.04 ± 1.49 27.40 ± 2.42 27.39 ± 2.49 29.99 ± 2.65
24:5 (n-3) 0.24 ± 0.03 0.26 ± 0.04 0.25 ± 0.04 0.25 ± 0.03
∑PUFA 53.62 ± 1.39 52.52 ± 2.63 53.21 ± 2.50 56.12 ± 2.28
∑(n-6) PUFA 5.96 ± 0.22 5.96 ± 0.13 6.02 ± 0.19 6.00 ± 0.19
∑(n-3) PUFA 47.18 ± 1.53 46.07 ± 2.73 46.69 ± 2.67 49.73 ± 2.40
(n-3)/(n-6) 7.93 ± 0.47 7.74 ± 0.55 7.77 ± 0.64 8.31 ± 0.56
Amount of Cholesterol (%) 0.06 ± 0.01 0.06 ± 0.02 0.07 ± 0.02 0.07 ± 0.02
Amount of FA (%) 0.74 ± 0.05 0.78 ± 0.14 0.83 ± 0.10 0.84 ± 0.07  
 75 
 
Table A9.  
Fatty acid profile in haddock muscle from the different treatments groups after one week recovery. FA 
that represents less than 0.1 % of the total FAs are removed from the table, but is included in the total 
sum of FAs. Data presented as average ± stdev. Bold numbers indicate significant differences 
compared with control, p< 0.05. 
19/6 19/6 19/6 19/6
Muscle Control PW Oil PAH
(n=10) (n=9) (n=11) (n=9)
 14:0 2.35 ± 0.21 2.44 ± 0.35 2.02 ± 0.41 2.19 ± 0.54
Iso 15:0 0.09 ± 0.01 0.09 ± 0.02 0.07 ± 0.01 0.08 ± 0.02
 15:0 0.33 ± 0.01 0.34 ± 0.03 0.30 ± 0.03 0.31 ± 0.05
 16:0 17.09 ± 0.87 17.26 ± 0.64 17.60 ± 0.64 17.68 ± 0.71
Iso 17:0 0.24 ± 0.04 0.26 ± 0.04 0.23 ± 0.03 0.24 ± 0.04
Antiso 17:0 0.06 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.06 ± 0.00
 17:0 0.18 ± 0.02 0.18 ± 0.02 0.18 ± 0.02 0.18 ± 0.02
 18:0 2.86 ± 0.30 2.88 ± 0.30 3.19 ± 0.48 3.10 ± 0.62
 20:0 0.03 ± 0.00 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01
∑SFA 23.60 ± 0.87 23.89 ± 0.60 24.04 ± 0.66 24.19 ± 0.70
16:1 (n-11) 0.18 ± 0.03 0.18 ± 0.02 0.16 ± 0.03 0.16 ± 0.03
16:1 (n-9) 0.34 ± 0.05 0.35 ± 0.04 0.31 ± 0.05 0.32 ± 0.06
16:1 (n-7) 2.11 ± 0.28 2.15 ± 0.30 1.87 ± 0.40 1.97 ± 0.44
16:1 (n-5) 0.27 ± 0.01 0.27 ± 0.02 0.24 ± 0.03 0.25 ± 0.04
∑17:1 0.61 ± 0.18 0.61 ± 0.18 0.51 ± 0.10 0.66 ± 0.23
18:1 (n-11) 1.70 ± 0.40 1.66 ± 0.34 1.39 ± 0.46 1.37 ± 0.55
18:1 (n-9) 9.29 ± 0.93 9.05 ± 0.80 8.85 ± 1.07 8.92 ± 0.90
18:1 (n-7) 2.37 ± 0.09 2.35 ± 0.14 2.36 ± 0.13 2.35 ± 0.09
18:1 (n-5) 0.34 ± 0.03 0.33 ± 0.02 0.31 ± 0.05 0.31 ± 0.04
20:1 (n-11) 0.46 ± 0.06 0.52 ± 0.07 0.48 ± 0.07 0.43 ± 0.09
20:1 (n-9) 2.40 ± 0.28 2.34 ± 0.28 2.31 ± 0.40 2.13 ± 0.40
20:1 (n-7) 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.01 0.04 ± 0.01
22:1 (n-11) 1.45 ± 0.30 1.27 ± 0.29 1.30 ± 0.32 1.08 ± 0.26
22:1 (n-9) 0.17 ± 0.03 0.16 ± 0.03 0.16 ± 0.03 0.14 ± 0.03
22:1 (n-7) 0.04 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01
24:1 (n-9) 0.94 ± 0.12 0.98 ± 0.15 1.04 ± 0.11 0.87 ± 0.07
24:1 (n-7) 0.12 ± 0.04 0.15 ± 0.06 0.14 ± 0.06 0.12 ± 0.04
∑MUFA 22.87 ± 1.98 22.48 ± 1.27 21.55 ± 2.47 21.19 ± 2.41
16:4 (n-1) 0.01 ± 0.01 0.02 ± 0.01 0.01 ± 0.00 0.01 ± 0.00
18:4 (n-1) 0.07 ± 0.01 0.08 ± 0.02 0.07 ± 0.02 0.07 ± 0.02
16:2 (n-4) 0.11 ± 0.02 0.12 ± 0.02 0.09 ± 0.02 0.10 ± 0.03
16:3 (n-4) 0.03 ± 0.01 0.04 ± 0.01 0.03 ± 0.01 0.04 ± 0.01
18:2 (n-4) 0.11 ± 0.01 0.11 ± 0.01 0.10 ± 0.01 0.11 ± 0.01
18:2 (n-6) 3.62 ± 0.12 3.61 ± 0.18 3.44 ± 0.25 3.46 ± 0.25
18:3 (n-6) 0.05 ± 0.01 0.05 ± 0.01 0.05 ± 0.00 0.05 ± 0.01
20:2 (n-6) 0.34 ± 0.03 0.39 ± 0.04 0.35 ± 0.07 0.35 ± 0.06
20:3 (n-6) 0.09 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.10 ± 0.01
20:4 (n-6) 1.13 ± 0.06 1.11 ± 0.08 1.22 ± 0.17 1.22 ± 0.16
22:4 (n-6) 0.16 ± 0.02 0.15 ± 0.03 0.16 ± 0.02 0.16 ± 0.02
22:5 (n-6) 0.41 ± 0.02 0.40 ± 0.02 0.44 ± 0.05 0.43 ± 0.05
18:3 (n-3) 0.70 ± 0.05 0.72 ± 0.06 0.63 ± 0.09 0.65 ± 0.10
18:4 (n-3) 0.99 ± 0.10 1.05 ± 0.11 0.89 ± 0.14 0.94 ± 0.16
20:3  (n-3) 0.10 ± 0.01 0.10 ± 0.01 0.09 ± 0.02 0.09 ± 0.02
20:4 (n-3) 0.67 ± 0.03 0.67 ± 0.03 0.63 ± 0.09 0.62 ± 0.09
20:5 (n-3) 14.91 ± 0.62 14.81 ± 0.43 14.34 ± 0.55 14.81 ± 0.56
21:5 (n-3) 0.29 ± 0.01 0.25 ± 0.09 0.27 ± 0.02 0.27 ± 0.03
22:5 (n-3) 1.67 ± 0.07 1.68 ± 0.04 1.70 ± 0.07 1.68 ± 0.06
22:6 (n-3) 27.73 ± 1.27 27.75 ± 1.20 29.50 ± 2.55 29.05 ± 2.95
24:5 (n-3) 0.17 ± 0.06 0.28 ± 0.05 0.15 ± 0.07 0.24 ± 0.04
∑PUFA 53.54 ± 1.67 53.63 ± 1.16 54.41 ± 2.10 54.62 ± 2.11
∑(n-6) PUFA 5.83 ± 0.14 5.83 ± 0.21 5.78 ± 0.22 5.79 ± 0.14
∑(n-3) PUFA 47.30 ± 1.66 47.38 ± 1.26 48.26 ± 2.19 48.43 ± 2.27
(n-3)/(n-6) 8.12 ± 0.30 8.14 ± 0.41 8.37 ± 0.57 8.38 ± 0.59
Amount of Cholesterol (%) 0.07 ± 0.02 0.07 ± 0.02 0.07 ± 0.02 0.06 ± 0.01
Amount of FA (%) 0.75 ± 0.11 0.77 ± 0.10 0.74 ± 0.13 0.76 ± 0.12  
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Table A10. Fatty acid profile in the pellets use in the experiment. FA that represents less than 0.1 % of 
the total FAs are removed from the table, but is included in the total sum of FAs. 
Food
(n=4)
 14:0 6.97 ± 0.17
Iso 15:0 0.25 ± 0.01
 15:0 0.45 ± 0.00
 16:0 14.64 ± 0.31
Iso 17:0 0.26 ± 0.00
Antiso 17:0 0.08 ± 0.00
 17:0 0.19 ± 0.01
 18:0 1.48 ± 0.04
 20:0 0.18 ± 0.00
∑SFA 24.95 ± 0.22
16:1 (n-11) 0.10 ± 0.00
16:1 (n-9) 0.24 ± 0.00
16:1 (n-7) 5.06 ± 0.01
16:1 (n-5) 0.30 ± 0.00
∑17:1 0.44 ± 0.01
18:1 (n-11) 0.59 ± 0.01
18:1 (n-9) 8.18 ± 0.22
18:1 (n-7) 1.94 ± 0.06
18:1 (n-5) 0.43 ± 0.02
20:1 (n-11) 0.98 ± 0.00
20:1 (n-9) 9.99 ± 0.07
20:1 (n-7) 0.26 ± 0.01
22:1 (n-11) 15.79 ± 0.59
22:1 (n-9) 0.99 ± 0.03
22:1 (n-7) 0.16 ± 0.02
24:1 (n-9) 1.10 ± 0.06
24:1 (n-7) 0.05 ± 0.01
∑MUFA 46.65 ± 0.41
16:4 (n-1) 0.44 ± 0.04
18:4 (n-1) 0.12 ± 0.01
16:2 (n-4) 0.36 ± 0.01
16:3 (n-4) 0.21 ± 0.01
18:2 (n-4) 0.09 ± 0.01
18:2 (n-6) 4.51 ± 0.14
18:3 (n-6) 0.08 ± 0.01
20:2 (n-6) 0.17 ± 0.00
20:3 (n-6) 0.04 ± 0.00
20:4 (n-6) 0.32 ± 0.02
22:4 (n-6) 0.03 ± 0.00
22:5 (n-6) 0.11 ± 0.01
18:3 (n-3) 1.17 ± 0.00
18:4 (n-3) 2.36 ± 0.05
20:3  (n-3) 0.09 ± 0.00
20:4 (n-3) 0.44 ± 0.02
20:5 (n-3) 6.39 ± 0.08
21:5 (n-3) 0.25 ± 0.00
22:5 (n-3) 0.78 ± 0.03
22:6 (n-3) 9.64 ± 0.15
24:5 (n-3) 0.50 ± 0.03
∑PUFA 28.40 ± 0.28
∑(n-6) PUFA 5.30 ± 0.15
∑(n-3) PUFA 21.77 ± 0.23
(n-3)/(n-6) 4.11 ± 0.10
Amount of Cholesterol (%) 0.34 ± 0.01
Amount of FA (%) 12.90 ± 0.45  
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Pilot study of mass spectrometry identification of DNA adducts.  
One aim for this project was to generate samples with very high levels of DNA adducts from PAH 
exposure that could be used into future method development of mass spectrometric analysis of PAH 
derived DNA adducts in haddock livers. The goal would be to identify the major DNA-adducts 
generated in haddock during PAH exposure and to create a mass spectra library that could be used for 
comparison in future field studies.  
An ultra-high performance Liquid chromatography coupled to tandem mass spectrometry (UHPLC 
MS/MS) method for the detection of DNA adducts, is currently under development by the ADn’tox 
partner PRISMM (an academic platform of the University of Caen, France). The method is now suitable 
for detection of the major BAP adduct: benzo(a)pyrene (BP)-7,8-diol-9,10-epoxide-N(2)-
deoxyguanosine (BPDE-dG) in the MRM (Multi Reaction Monitoring) mode, but can also be used for 
the pre-screening of multi-adduct detection in the PNL (Pseudo Neutral Loss) mode. The later mode is 
focused on the loss of the deoxyribose (dR) from the protonated DNA adducts ([M+H-116]+), a 
particular fragmentation common to all nucleosides in MS, including the parent dG DNA adducts.  
In this project a small pilot study with LC-MS analysis was performed. Two samples were selected for 
UHPLC-MS/MS, one from the PAH exposed group, n◦38 (D18) (DNA adduct 40 nmol adduct/mol 
normal DNA), and one control n◦5 (DNA adduct not detected) (Figure A1). Both fish were sampled 2 
months after start of the experiment. The autoradiograms of these two samples can be seen in figure 
10. 
 
The samples were analysed on UHPLC-MS/MS with several different scan methods; 
Test 1: Target multiple reaction monitoring (MRM) for the known BAP DNA-adduct, dG-N-2-BPDE. 
Test 2: Non target pseudo neutral loss scanning (PNL). This is a screening method looking for 
“unknown” DNA adducts. 
Test 3. Target MRM scanning for 8-Oxo-2'-deoxyguanosine (8-oxo-dG). 8-oxo-dG is an oxidized 
derivative of deoxyguanosine and is one of the major products of DNA oxidation. Concentrations of 8-
oxo-dG within a cell are a measurement of oxidative stress. 
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Preliminary results of the 3 UHPLC-MS/MS tests  
 
Figure A1. HPLC-MS/MS analysis (MRM scanning for dG BPDE) of a selected haddock sample (PAH exposed for 2 
months, sample no38) and a positive control sample with a known amount of dG BPDE. The MRM scan shows 
that dG BPDE was not detected in the haddock sample. 
 
Test 1 showed no presence of the known BaP-DNA adduct found in the oral exposed haddock. In the 
MRM mode, the detection of BPDE-dG is associated to the matching of signals (peaks) in both 
transition patterns 570>454; 570>257. Peaks associated with this adduct appeared after 2 minutes 
elution (see positive control, Figure A1). On this basis, the patterns obtained with sample n°38 show 
the absence of dG-BPDE adduct at the limit of detection of 0.6 nM. The autoradiogram of this sample 
(Figure 10, sample no38)) showed a large “spot 1” and two minor peaks in the “spot 2/3” area. This 
suggest that BaP produce other DNA adducts in haddock that what have been identified inn mammals. 
Test 2 in the PNL mode, interesting signals are simultaneously observed in both transition patterns 
538>422 (2 peaks) and 537>421 (3 peaks). These signals would be associated to 2 and 3 isomers of 2 
different DNA adducts. The comparison of the PNL patterns obtained from both samples n°5 
(unexposed control haddock) and n°38 (PAH exposed haddock) reveals that this peaks are only found 
in the PAH exposed fish (Figure A2). On the basis of the “Nitrogen rule”, some potential chemical 
structures are proposed. One of both supposed DNA adducts probably contains nitrogen atom (in NH2 
or NO2 functions) (Figure A4). It remains to get a positive identification through analysing standards, 
but it shows that the LC-MS/MS is sensitive enough to detect DNA adducts in this samples. 
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Figure A2. HPLC-MS/MS analyses (PNL scanning) of selected haddock sample (PAH exposed in 2 months, sample 
no38) and negative control sample (sample no5). 
 
 
Figure A3. Suggestion of potential DNA adducts of BaP or BeP that can correspond to the scanning signals found 
in Figure A3. These results need to be confirmed by analyzing standards of the different DNA adducts. 
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Figure A4. HPLC-MS/MS analyses (MRM scanning for 8-oxo-dG) of selected haddock sample (PAH exposed in 2 
month) and negative control sample. 
Test 3, the 8-hydroxy-2'-deoxyguanosine (8-OH-dG), a well-known DNA adduct used as marker of 
oxidative stress of various origins, is detected with higher level by the MRM mode in sample n°38 
compared to n°5. Analyses of 8-oxo-dG have been suggested as measurement of oxidative stress from 
PAH exposure (Isabel et al. 2012;Penning 2014) and it may be an interesting parameter to consider to 
include in the water column survey.  
 
